Research Articles

Epidemiology

Disease Burden/ Trend

 

Risk factors

Risk factors for kala-azar in Bangladesh.

Bern C, Hightower AW, Chowdhury R, Ali M, Amann J, Wagatsuma Y, Haque R, Kurkjian K, Vaz LE, Begum M, Akter T, Cetre-Sossah CB, Ahluwalia IB, Dotson E, Secor WE, Breiman RF, Maguire JH.
Emerg Infect Dis. 2005 May;11(5):655-62.PMID:15890115

Risk factors for visceral Leishmaniasis among residents and migrants in Kafta-Humera, Ethiopia.

Argaw D, Mulugeta A, Herrero M, Nombela N, Teklu T, Tefera T, Belew Z, Alvar J, Bern C.
PLoS Negl Trop Dis. 2013 Nov 7;7(11):e2543. doi: 10.1371/journal.pntd.0002543. eCollection 2013 Nov.PMID:24244778

Of cattle, sand flies and men: a systematic review of risk factor analyses for South Asian visceral leishmaniasis and implications for elimination.

Bern C, Courtenay O, Alvar J.
PLoS Negl Trop Dis. 2010 Feb 9;4(2):e599. doi: 10.1371/journal.pntd.0000599. Review. Erratum in: PLoS Negl Trop Dis. 2010;4(3). doi: 10.1371/annotation/f96dd2ce-05de-4aa5-a9d5-c481b0745c84. PMID:20161727

Risk factors for visceral leishmaniasis in a new epidemic site in Amhara Region, Ethiopia.

Bashaye S, Nombela N, Argaw D, Mulugeta A, Herrero M, Nieto J, Chicharro C, Cañavate C, Aparicio P, Vélez ID, Alvar J, Bern C.
Am J Trop Med Hyg. 2009 Jul;81(1):34-9.PMID:19556563

Visceral leishmaniasis: adult population of Abbottabad at risk now.

Idris M, Farid J, Gul N, Anis-ur-Rehman.
J Ayub Med Coll Abbottabad. 2010 Apr-Jun;22(2):214-5.PMID:21702307

Epidemiological study of risk factors related to childhood visceral leishmaniasis.

Rukunuzzaman M, Rahman M.
Mymensingh Med J. 2008 Jan;17(1):46-50.PMID:18285731

Asymptomatic VL

The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village.

Bern C, Haque R, Chowdhury R, Ali M, Kurkjian KM, Vaz L, Amann J, Wahed MA, Wagatsuma Y, Breiman RF, Williamson J, Secor WE, Maguire JH.
Am J Trop Med Hyg. 2007 May;76(5):909-14.PMID:17488915

Co-infection

First case of pulmonary tuberculosis and visceral leishmaniasis coinfection successfully treated with antituberculosis drug and liposomal amphotericin B.

Hasnain MG, Ghosh P, Sharafat Sonin MS, Baker J, Mondal D.

Clin Case Rep. 2014 Dec;2(6):331-2. doi: 10.1002/ccr3.130. Epub 2014 Sep 4.PMID: 25548640

Transmission Dynamics/ Outbreak

 

Post Kala-azar Dermal Leishmanisis (PKDL)

Post-Kala-Azar Dermal Leishmaniasis without Previous History of Visceral Leishmaniasis.

Hasnain MG, Shomik MS, Ghosh P, Rashid MO, Hossain MS, Hamano S, Mondal D.
Am J Trop Med Hyg. 2016 Sep 26. pii: 16-0230. [Epub ahead of print] PMID:27672208

A Comparison of the Effectiveness of Sodium Stibogluconate Monotherapy to Sodium Stibogluconate and Paromomycin Combination for the Treatment of Severe Post Kala Azar Dermal Leishmaniasis in South Sudan – A Retrospective Cohort Study.

Abongomera C, Gatluak F, Buyze J, Ritmeijer K.
PLoS One. 2016 Sep 22;11(9):e0163047. doi: 10.1371/journal.pone.0163047. eCollection 2016. PMID: 27658288

Clinical and immunological aspects of post-kala-azar dermal leishmaniasis in Bangladesh.

Islam S, Kenah E, Bhuiyan MA, Rahman KM, Goodhew B, Ghalib CM, Zahid MM, Ozaki M, Rahman MW, Haque R, Luby SP, Maguire JH, Martin D, Bern C.
Am J Trop Med Hyg. 2013 Aug;89(2):345-53. doi: 10.4269/ajtmh.12-0711. Epub 2013 Jul 1.PMID:23817330

Economic consequences of post-kala-azar dermal leishmaniasis in a rural Bangladeshi community.

Ozaki M, Islam S, Rahman KM, Rahman A, Luby SP, Bern C.
Am J Trop Med Hyg. 2011 Sep;85(3):528-34. doi: 10.4269/ajtmh.2011.10-0683.

PMID:21896817


Post-Kala-Azar dermal leishmaniasis in Mymensingh, Bangladesh.

Islam S, Ashraful Alam Bhuiyan M, Bern C.
Am J Trop Med Hyg. 2011 Aug;85(2):193-4. doi: 10.4269/ajtmh.2011.11-0128. No abstract available. PMID:21813832

Increasing incidence of post-kala-azar dermal leishmaniasis in a population-based study in Bangladesh.

Rahman KM, Islam S, Rahman MW, Kenah E, Ghalib CM, Zahid MM, Maguire J, Rahman M, Haque R, Luby SP, Bern C.
Clin Infect Dis. 2010 Jan 1;50(1):73-6. doi: 10.1086/648727. Erratum in: Clin Infect Dis. 2010 May 1;50(9):1329. Galive, Chowdhury Mohammad [corrected to Ghalib, Chowdhury Mohammad]. PMID:19951168

Study on the safety and efficacy of miltefosine for the treatment of children and adolescents with post-kala-azar dermal leishmaniasis in Bangladesh, and an association of serum vitamin E and exposure to arsenic with post-kala-azar dermal leishmaniasis: an open clinical trial and case-control study protocol.

Mondal D, Hasnain MG, Hossain MS, Ghosh D, Ghosh P, Hossain H, Baker J, Nath R, Haque R, Matlashewski G, Hamano S.
BMJ Open. 2016 May 17;6(5):e010050. doi: 10.1136/bmjopen-2015-010050. PMID:27188804

A Study on Health Seeking Behaviors of Patients of Post-Kala-Azar Dermal Leishmaniasis.

Basher A, Nath P, Nabi SG, Selim S, Rahman MF, Sutradhar SR, Faiz A, Bhuiyan MR, Ahmed BN, Rahman R.
Biomed Res Int. 2015;2015:314543. doi: 10.1155/2015/314543.PMID:26788500

Decreased presence of Langerhans cells is a critical determinant for Indian Post kala-azar dermal leishmaniasis.

Mukherjee S, Mukhopadhyay D, Braun C, Barbhuiya JN, Das NK, Chatterjee U, von Stebut E, Chatterjee M.
Exp Dermatol. 2015 Mar;24(3):232-4. doi: 10.1111/exd.12635.PMID:25580856

Post-Kala-azar dermal leishmaniasis ( a review of 10 cases).

Khan HM.
Bangladesh Med Res Counc Bull. 1977 Dec;3(2):130-6.PMID:615589
Diagnosis

Visceral leishmaniasis (VL)

Evaluation of diagnostic performance of rK28 ELISA using urine for diagnosis of visceral leishmaniasis.

Ghosh P, Bhaskar KR, Hossain F, Khan MA, Vallur AC, Duthie MS, Hamano S, Salam MA, Huda MM, Khan MG, Coler RN, Reed SG, Mondal D.
Parasit Vectors. 2016 Jul 4;9(1):383. doi: 10.1186/s13071-016-1667-2.PMID:27377266

Mobile suitcase laboratory for rapid detection of Leishmania donovani using recombinase polymerase amplification assay.

Mondal D, Ghosh P, Khan MA, Hossain F, Böhlken-Fascher S, Matlashewski G, Kroeger A, Olliaro P, Abd El Wahed A.
Parasit Vectors. 2016 May 13;9(1):281. doi: 10.1186/s13071-016-1572-8.PMID:27177926

Accurate Serodetection of Asymptomatic Leishmania donovani Infection by Use of Defined Antigens.

Vallur AC, Reinhart C, Mohamath R, Goto Y, Ghosh P, Mondal D, Duthie MS, Reed SG.
J Clin Microbiol. 2016 Apr;54(4):1025-30. doi: 10.1128/JCM.02620-15. Epub 2016 Feb 3.PMID:26842701

Polymerase Chain Reaction in the Diagnosis of Visceral Leishmaniasis Recurrence in the Setting of Negative Splenic Smears.

Hasnain G, Basher A, Nath P, Ghosh P, Hossain F, Hossain S, Mondal D.
Am J Trop Med Hyg. 2016 Jan;94(1):99-101. doi: 10.4269/ajtmh.15-0136. Epub 2015 Nov 10.PMID: 26556834

Development and comparative evaluation of two antigen detection tests for Visceral Leishmaniasis.

Vallur AC, Tutterrow YL, Mohamath R, Pattabhi S, Hailu A, Abdoun AO, Ahmed AE, Mukhtar M, Salam MA, Almeida ML, Almeida RP, Mondal D, Albertini A, Ghalib H, Duthie MS, Reed SG.
BMC Infect Dis. 2015 Sep 22;15:384. doi: 10.1186/s12879-015-1125-3.PMID:26395447

A comparative evaluation of the performance of commercially available rapid immunochromatographic tests for the diagnosis of visceral leishmaniasis in Bangladesh.

Ghosh P, Hasnain MG, Ghosh D, Hossain F, Baker J, Boelaert M, Rijal S, Mondal D.
Parasit Vectors. 2015 Jun 16;8:331. doi: 10.1186/s13071-015-0935-x.PMID:26077956

An evaluation of the performance of direct agglutination test on filter paper blood sample for the diagnosis of visceral leishmaniasis.

Hasnain MG, Ghosh P, Baker J, Mondal D.
Am J Trop Med Hyg. 2014 Aug;91(2):342-4. doi: 10.4269/ajtmh.13-0530. Epub 2014 Jun 23.PMID:24957542

Comparison of PCR-based diagnoses for visceral leishmaniasis in Bangladesh.

Khan MG, Bhaskar KR, Kikuchi M, Salam MA, Akther T, Haque R, Mondal D, Hamano S.
Parasitol Int. 2014 Apr;63(2):327-31. doi: 10.1016/j.parint.2013.12.001. Epub 2013 Dec 12.PMID:24333754

Diagnostic accuracy of loop-mediated isothermal amplification (LAMP) for detection of Leishmania DNA in buffy coat from visceral leishmaniasis patients.

Khan MG, Bhaskar KR, Salam MA, Akther T, Pluschke G, Mondal D.
Parasit Vectors. 2012 Dec 3;5:280. doi: 10.1186/1756-3305-5-280.PMID:23206441

Characterization of the recent clinical isolates of Indian Kala-azar patients by RAPD-PCR method.

Khanra S, Bandopadhyay SK, Chakraborty P, Datta S, Mondal D, Chatterjee M, Naskar K, Roy S, Manna M.
J Parasit Dis. 2011 Oct;35(2):116-22. Epub 2011 Jun 24.PMID:23024491

A global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasis.

Cunningham J, Hasker E, Das P, El Safi S, Goto H, Mondal D, Mbuchi M, Mukhtar M, Rabello A, Rijal S, Sundar S, Wasunna M, Adams E, Menten J, Peeling R, Boelaert M; WHO/TDR Visceral Leishmaniasis Laboratory Network.
Clin Infect Dis. 2012 Nov 15;55(10):1312-9. doi: 10.1093/cid/cis716. Epub 2012 Aug 31.PMID:22942208

Peripheral blood buffy coat smear: a promising tool for diagnosis of visceral leishmaniasis.

Salam MA, Khan MG, Bhaskar KR, Afrad MH, Huda MM, Mondal D.
J Clin Microbiol. 2012 Mar;50(3):837-40. doi: 10.1128/JCM.05067-11. Epub 2012 Jan 11.PMID:22205790

Design, development and evaluation of rK28-based point-of-care tests for improving rapid diagnosis of visceral leishmaniasis.

Pattabhi S, Whittle J, Mohamath R, El-Safi S, Moulton GG, Guderian JA, Colombara D, Abdoon AO, Mukhtar MM, Mondal D, Esfandiari J, Kumar S, Chun P, Reed SG, Bhatia A.
PLoS Negl Trop Dis. 2010 Sep 14;4(9). pii: e822. doi: 10.1371/journal.pntd.0000822. PMID:20856856

Loss of leishmanin skin test antigen sensitivity and potency in a longitudinal study of visceral leishmaniasis in Bangladesh.

Bern C, Amann J, Haque R, Chowdhury R, Ali M, Kurkjian KM, Vaz L, Wagatsuma Y, Breiman RF, Secor WE, Maguire JH.
Am J Trop Med Hyg. 2006 Oct;75(4):744-8.PMID:17038705

Evaluation of two rK39 dipstick tests, direct agglutination test, and indirect fluorescent antibody test for diagnosis of visceral leishmaniasis in a new epidemic site in highland Ethiopia.

Cañavate C, Herrero M, Nieto J, Cruz I, Chicharro C, Aparicio P, Mulugeta A, Argaw D, Blackstock AJ, Alvar J, Bern C.
Am J Trop Med Hyg. 2011 Jan;84(1):102-6. doi: 10.4269/ajtmh.2011.10-0229.PMID:21212210

Multiplex analysis of circulating cytokines in the sera of patients with different clinical forms of visceral leishmaniasis.

Kurkjian KM, Mahmutovic AJ, Kellar KL, Haque R, Bern C, Secor WE.
Cytometry A. 2006 May;69(5):353-8.PMID:16604536

Application of an improved method for the recombinant k 39 enzyme-linked immunosorbent assay to detect visceral leishmaniasis disease and infection in Bangladesh.

Kurkjian KM, Vaz LE, Haque R, Cetre-Sossah C, Akhter S, Roy S, Steurer F, Amann J, Ali M, Chowdhury R, Wagatsuma Y, Williamson J, Crawford S, Breiman RF, Maguire JH, Bern C, Secor WE.
Clin Diagn Lab Immunol. 2005 Dec;12(12):1410-5.PMID:16339064

Use of the recombinant K39 dipstick test and the direct agglutination test in a setting endemic for visceral leishmaniasis in Nepal.

Bern C, Jha SN, Joshi AB, Thakur GD, Bista MB.
Am J Trop Med Hyg. 2000 Sep-Oct;63(3-4):153-7.PMID:11388508

PCR-based detection of Leishmania donovani DNA in a stray dog from a visceral Leishmaniasis endemic focus in Bangladesh.

Alam MZ, Yasin G, Kato H, Sakurai T, Katakura K.
J Vet Med Sci. 2013 Jan 31;75(1):75-8. Epub 2012 Aug 10.PMID:22878541

ELISA with recombinant rKRP42 antigen using urine samples: a tool for predicting clinical visceral leishmaniasis cases and its outbreak.

Islam MZ, Itoh M, Ul Islam MA, Saifuddin Ekram AR, Rahman MA, Takagi H, Takesue A, Hashiguchi Y, Kimura E.
Am J Trop Med Hyg. 2012 Oct;87(4):658-62. doi: 10.4269/ajtmh.2012.12-0168. Epub 2012 Aug 6.PMID:22869633

Spectrum of skin lesions of post-kala-azar dermal leishmaniasis in kala-azar endemic areas of Bangladesh.

Sultana A, Zakaria SM, Bhuiyan SI, Habib A, Dey SK, Rahman M, Basher A.
Mymensingh Med J. 2012 Jul;21(3):529-32.PMID:22828555

PCR-based detection of Leishmania DNA in skin samples of post kala-azar dermal leishmaniasis patients from an endemic area of Bangladesh.

Nasreen SA, Hossain MA, Paul SK, Mahmud MC, Ahmed S, Ghosh S, Kobayashi N.
Jpn J Infect Dis. 2012 Jul;65(4):315-7.PMID:22814154

Short communication: evaluation of a new rapid diagnostic test for quality assurance by kala azar elimination programme in bangladesh.

Khan MG, Alam MS, Bhuiyan AT, Jamil MA, Saha B, Islam M, Haque R, Hossain M, Jamil KM.
J Parasitol Res. 2011;2011:862475. doi: 10.1155/2011/862475. Epub 2011 Nov 2. PMID:22132308

Evaluation of rK-39 strip test using urine for diagnosis of visceral leishmaniasis in an endemic area in Bangladesh.

Khan MG, Alam MS, Podder MP, Itoh M, Jamil KM, Haque R, Wagatsuma Y.
Parasit Vectors. 2010 Nov 26;3:114. doi: 10.1186/1756-3305-3-114. PMID:21110875

Sensitivity, specificity and predictive values of immunochromatographic strip test in diagnosis of childhood kala-azar.

Rouf MA, Rahman ME, Islam MN, Islam MN, Ferdous NN, Hossain MA.
Mymensingh Med J. 2009 Jan;18(1 Suppl):S1-5.PMID:19377416

Antigen detection from urine of Kala-azar cases by latex agglutination test.

Alam M, Shamsuzzaman A, Musa A, Khan A, Mahmud M, Hossain M, Ahmed A.
Mymensingh Med J. 2008 Jan;17(1):22-7.PMID:18285726

Diagnostic efficacy of Aldehyde test in late cases of Kala-azar.

Parvin R, Rahman ME, Islam MN, Uddin SN, Khaleque MA, Choudhury AM.
Mymensingh Med J. 2007 Jul;16(2):160-4.PMID:17703152

Sensitivity of splenic and bone marrow aspirate study for diagnosis of kala-azar.

Sarker CB, Alam KS, Jamal MF, Rahman S, Huq MH, Musa AK, Sutradhar SR, Talukder SI, Debnath CR.
Mymensingh Med J. 2004 Jul;13(2):130-3.PMID:15284686

Immunochromatographic (rK39) strip test in the diagnosis of visceral leishmaniasis in Bangladesh.

Sarker CB, Momen A, Jamal MF, Siddiqui NI, Siddiqui FM, Chowdhury KS, Rahman S, Talukder SI.
Mymensingh Med J. 2003 Jul;12(2):93-7.PMID:12894040

Comparative studies on IFAT, ELISA & DAT for serodiagnosis of visceral leishmaniasis in Bangladesh.

Alam MJ, Rahman KM, Asna SM, Muazzam N, Ahmed I, Chowdhury MZ.
Bangladesh Med Res Counc Bull. 1996 Apr;22(1):27-32.PMID:9037842

Evaluation of cleaving agents other than trypsin in direct agglutination test for further improving diagnosis of visceral leishmaniasis.

el Harith A, Chowdhury S, al-Masum A, Semião-Santos S, Karim E, el-Safi S, Haque I.
J Clin Microbiol. 1995 Aug;33(8):1984-8.PMID:7559934

Characterization of Leishmania isolated from patients with kala-azar and post kala-azar dermal leishmaniasis in Bangladesh.

el-Masum MA, Evans DA.
Trans R Soc Trop Med Hyg. 1995 May-Jun;89(3):331-2. No abstract available. PMID:7660453

Visceral leishmaniasis in Bangladesh: the value of DAT as a diagnostic tool.

el-Masum MA, Evans DA, Minter DM, el Harith A.
Trans R Soc Trop Med Hyg. 1995 Mar-Apr;89(2):185-6.PMID:7778144

Agglutinating anti-leishmanial antibodies in the saliva of kala-azar patients.

Masum MA, Evans DA.
Trans R Soc Trop Med Hyg. 1994 Nov-Dec;88(6):660. No abstract available. PMID:7886762

Applicability of direct agglutination test (DAT) at a rural health setting in Bangladesh and feasibility of local antigen production.

Chowdhury MS, al Masum A, al Karim E, Semiáo-Santos S, Rahman KM, Ar-Rashid H, el Harith A.
Arch Inst Pasteur Tunis. 1993 Jul-Oct;70(3-4):333-44.PMID:7802488

Prevalence of agglutinating anti-Leishmania antibodies in two multi-thousand Bengoli communities.

Chowdhury MS, el Harith A, al Massum A, al Karim E, al Rahman A.
Parasitol Res. 1993;79(6):444-50.PMID:8415555

Indirect fluorescent antibody test in the serodiagnosis of visceral leishmaniasis in Bangladesh.

Muazzam N, Rahman KM, Miah RA, Asna SM.
Bangladesh Med Res Counc Bull. 1992 Dec;18(2):77-81.PMID:1303085

Aldehyde test (Formol-Gel test) in the diagnosis of kala-azar (visceral leishmaniasis).

Chowdhury MA, Rafiqueuddin AK, Hussain A.
Trop Doct. 1992 Oct;22(4):185-6. No abstract available. PMID:1440905

Relapse/Treatment Failure VL

Post Kala-azar Dermal Leishmaniasis

Treatment

Visceral leishmaniasis (VL)

Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, North-West Ethiopia.

Tamiru A, Tigabu B, Yifru S, Diro E, Hailu A.
BMC Infect Dis. 2016 Oct 10;16(1):548.PMID:27724891

Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial.

Wasunna M, Njenga S, Balasegaram M, Alexander N, Omollo R, Edwards T, Dorlo TP, Musa B, Ali MH, Elamin MY, Kirigi G, Juma R, Kip AE, Schoone GJ, Hailu A, Olobo J, Ellis S, Kimutai R, Wells S, Khalil EA, Strub Wourgaft N, Alves F, Musa A.
PLoS Negl Trop Dis. 2016 Sep 14;10(9):e0004880. doi: 10.1371/journal.pntd.0004880. eCollection 2016 Sep. PMID:27627654

 

Relapse/Treatment Failure VL

Efficacy and safety of single-dose liposomal amphotericin B for visceral leishmaniasis in a rural public hospital in Bangladesh: a feasibility study.

Mondal D, Alvar J, Hasnain MG, Hossain MS, Ghosh D, Huda MM, Nabi SG, Sundar S, Matlashewski G, Arana B.
Lancet Glob Health. 2014 Jan;2(1):e51-7. doi: 10.1016/S2214-109X(13)70118-9. Epub 2013 Dec 5.PMID:25104636

Liposomal amphotericin B for the treatment of visceral leishmaniasis.

Bern C, Adler-Moore J, Berenguer J, Boelaert M, den Boer M, Davidson RN, Figueras C, Gradoni L, Kafetzis DA, Ritmeijer K, Rosenthal E, Royce C, Russo R, Sundar S, Alvar J.
Clin Infect Dis. 2006 Oct 1;43(7):917-24. Epub 2006 Aug 28.PMID:16941377

Post Kala-azar Dermal Leishmaniasis

Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh.

Jamil KM, Haque R, Rahman R, Faiz MA, Bhuiyan AT, Kumar A, Hassan SM, Kelly H, Dhalaria P, Kochhar S, Desjeux P, Bhuiyan MA, Khan MM, Ghosh RS.
PLoS Negl Trop Dis. 2015 Oct 23;9(10):e0004118. doi: 10.1371/journal.pntd.0004118. eCollection 2015.PMID:26496648

Effectiveness and safety of short course liposomal amphotericin B (AmBisome) as first line treatment for visceral leishmaniasis in Bangladesh.

Lucero E, Collin SM, Gomes S, Akter F, Asad A, Kumar Das A, Ritmeijer K.
PLoS Negl Trop Dis. 2015 Apr 2;9(4):e0003699. doi: 10.1371/journal.pntd.0003699. eCollection 2015 Apr.PMID:25837313

Miltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendations.

Monge-Maillo B, López-Vélez R.
Clin Infect Dis. 2015 May 1;60(9):1398-404. doi: 10.1093/cid/civ004. Epub 2015 Jan 18. Review.PMID:25601455

Specific antibody responses as indicators of treatment efficacy for visceral leishmaniasis.

Vallur AC, Hailu A, Mondal D, Reinhart C, Wondimu H, Tutterrow Y, Ghalib HW, Reed SG, Duthie MS.
Eur J Clin Microbiol Infect Dis. 2015 Apr;34(4):679-86. doi: 10.1007/s10096-014-2282-9. Epub 2014 Nov 19.PMID:25407374

Drug combinations for visceral leishmaniasis.

Olliaro PL.
Curr Opin Infect Dis. 2010 Dec;23(6):595-602. doi: 10.1097/QCO.0b013e32833fca9d. Review.PMID:20871400

Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent.

Meheus F, Balasegaram M, Olliaro P, Sundar S, Rijal S, Faiz MA, Boelaert M.
PLoS Negl Trop Dis. 2010 Sep 7;4(9). pii: e818. doi: 10.1371/journal.pntd.0000818. PMID:20838649

Barriers to treatment for visceral leishmaniasis in hyperendemic areas: India, Bangladesh, Nepal, Brazil and Sudan.

Thornton SJ, Wasan KM, Piecuch A, Lynd LL, Wasan EK.
Drug Dev Ind Pharm. 2010 Nov;36(11):1312-9. doi: 10.3109/03639041003796648. Review.PMID:20545513

Sodium stibogluconate-sensitive visceral leishmaniasis in the non-endemic hilly region of Uttarakhand, India.

Verma SK, Ahmad S, Shirazi N, Kusum A, Kaushik RM, Barthwal SP.
Trans R Soc Trop Med Hyg. 2007 Jul;101(7):730-2. Epub 2007 Mar 23.
PMID:17382981

Drug resistance mechanisms in clinical isolates of Leishmania donovani.

Singh N.
Indian J Med Res. 2006 Mar;123(3):411-22. Review.PMID:16778320

Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004.

Olliaro PL, Guerin PJ, Gerstl S, Haaskjold AA, Rottingen JA, Sundar S.
Lancet Infect Dis. 2005 Dec;5(12):763-74. Review.PMID:16310148

Progress in the treatment of a neglected infectious disease: visceral leishmaniasis.

Murray HW.
Expert Rev Anti Infect Ther. 2004 Apr;2(2):279-92. Review. Erratum in: Expert Rev Anti Infect Ther. 2004 Jun;2(3):462. PMID:15482193

Deaths in visceral leishmaniasis (Kala-azar) during treatment.

Ahasan HA, Chowdhury MA, Azhar MA, Rafiqueuddin AK, Azad KA.
Med J Malaysia. 1996 Mar;51(1):29-32.PMID:10967976

Does antimony therapy cause bleeding in kala-azar patients and why?

Chowdhury MA, Ahasan HA, Azhar MA, Rafiqueuddin AK, Islam MR, Misbahuddin M, Rashid MU.
Trop Doct. 1995 Oct;25(4):188-9. No abstract available. PMID:7502336
Case Report

Cutaneous leishmaniasis in an immigrant Saudi worker: a case report.

Rahman H, Razzak MA, Chanda BC, Bhaskar KR, Mondal D.

J Health Popul Nutr. 2014 Jun;32(2):372-6.PMID:25076674

Post-kala-azar dermal leishmaniasis with mucosal involvement: an unusual case presentation including successful treatment with miltefosine.

Salam MA, Siddiqui MA, Nabi SG, Bhaskar KR, Mondal D.

J Health Popul Nutr. 2013 Jun;31(2):294-7.PMID:23930349

A poor-quality generic drug for the treatment of visceral leishmaniasis: a case report and appeal.

Dorlo TP, Eggelte TA, Schoone GJ, de Vries PJ, Beijnen JH.
PLoS Negl Trop Dis. 2012;6(5):e1544. doi: 10.1371/journal.pntd.0001544. Epub 2012 May 29. No abstract available. PMID:22666507

A case of kala-azar diagnosed by bone marrow aspiration.

Hamidah NH, Cheong SK, Abu Hassan J.
Malays J Pathol. 1995 Jun;17(1):39-41.PMID:8907004

An historical review of malaria, kala-azar and filariasis in Bangladesh in relation to the Flood Action Plan.

Birley MH.
Ann Trop Med Parasitol. 1993 Aug;87(4):319-34. Review.PMID:8250623

Unusual features in kala-azar: a case report.

Chowdhury AH, Islam N.
Bangladesh Med Res Counc Bull. 1986 Dec;12(2):99-104. No abstract available.PMID:3566688
Review Article

Elimination of visceral leishmaniasis on the Indian subcontinent.

Singh OP, Hasker E, Boelaert M, Sundar S.

Lancet Infect Dis. 2016 Sep 28. pii: S1473-3099(16)30140-2. doi: 10.1016/S1473-3099(16)30140-2. Review.PMID:27692643

Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent – A Systematic Literature Review.

Hirve S, Boelaert M, Matlashewski G, Mondal D, Arana B, Kroeger A, Olliaro P.

PLoS Negl Trop Dis. 2016 Aug 4;10(8):e0004896. doi: 10.1371/journal.pntd.0004896. eCollection 2016 Aug. PMID: 27490264


Research priorities for elimination of visceral leishmaniasis.

Matlashewski G, Arana B, Kroeger A, Be-Nazir A, Mondal D, Nabi SG, Banjara MR, Das ML, Marasini B, Das P, Medley G, Satoskar A, Nakhasi H, Argaw D, Reeder J, Olliaro P.

Lancet Glob Health. 2014 Dec;2(12):e683-4. doi: 10.1016/S2214-109X(14)70318-3. No abstract available. PMID:25433617

Recent advances in post-kala-azar dermal leishmaniasis.

Mondal D, Khan MG.

Curr Opin Infect Dis. 2011 Oct;24(5):418-22. doi: 10.1097/QCO.0b013e32834a8ba1. Review.PMID:21885919

Visceral leishmaniasis: elimination with existing interventions.

Matlashewski G, Arana B, Kroeger A, Battacharya S, Sundar S, Das P, Sinha PK, Rijal S, Mondal D, Zilberstein D, Alvar J.

Lancet Infect Dis. 2011 Apr;11(4):322-5. doi: 10.1016/S1473-3099(10)70320-0. Review.PMID:21453873

Complexities of assessing the disease burden attributable to leishmaniasis.

Bern C, Maguire JH, Alvar J.
PLoS Negl Trop Dis. 2008;2(10):e313. doi: 10.1371/journal.pntd.0000313. Epub 2008 Oct 29. Review.PMID:18958165

Recent advances in the diagnosis and treatment of kala-azar.

Sundar S, Chakravarty J.
Natl Med J India. 2012 Mar-Apr;25(2):85-9. Review.PMID:22686715
Drug Development
Vaccine

From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE.

Coler RN, Duthie MS, Hofmeyer KA, Guderian J, Jayashankar L, Vergara J, Rolf T, Misquith A, Laurance JD, Raman VS, Bailor HR, Cauwelaert ND, Reed SJ, Vallur A, Favila M, Orr MT, Ashman J, Ghosh P, Mondal D, Reed SG.

Clin Transl Immunology. 2015 Apr 10;4(4):e35. doi: 10.1038/cti.2015.6. eCollection 2015 Apr.PMID:26175894

Leishmaniasis vaccine candidates for development: a global overview.

Khamesipour A, Rafati S, Davoudi N, Maboudi F, Modabber F.
Indian J Med Res. 2006 Mar;123(3):423-38. Review.PMID:16778321
Genetics & Leishmaniasis
Vector Control / Entomology

Entomological efficacy of durable wall lining with reduced wall surface coverage for strengthening visceral leishmaniasis vector control in Bangladesh, India and Nepal.

Huda MM, Kumar V, Das ML, Ghosh D, Priyanka J, Das P, Alim A, Matlashewski G, Kroeger A, Alfonso-Sierra E, Mondal D.

BMC Infect Dis. 2016 Oct 6;16(1):539.PMID: 27716091

Efficacy, Safety and Cost of Insecticide Treated Wall Lining, Insecticide Treated Bed Nets and Indoor Wall Wash with Lime for Visceral Leishmaniasis Vector Control in the Indian Sub-continent: A Multi-country Cluster Randomized Controlled Trial.

Mondal D, Das ML, Kumar V, Huda MM, Das P, Ghosh D, Priyanka J, Matlashewski G, Kroeger A, Upfill-Brown A, Chowdhury R.

PLoS Negl Trop Dis. 2016 Aug 17;10(8):e0004932. doi: 10.1371/journal.pntd.0004932. eCollection 2016 Aug. PMID: 27533097

Implication of vector characteristics of Phlebotomus argentipes in the kala-azar elimination programme in the Indian sub-continent.

Chowdhury R, Kumar V, Mondal D, Das ML, Das P, Dash AP, Kroeger A.

Pathog Glob Health. 2016 May;110(3):87-96. doi: 10.1080/20477724.2016.1180775.PMID: 27376500

Reducing visceral leishmaniasis by insecticide impregnation of bed-nets, Bangladesh.

Mondal D, Huda MM, Karmoker MK, Ghosh D, Matlashewski G, Nabi SG, Kroeger A.

Emerg Infect Dis. 2013 Jul;19(7):1131-4. doi: 10.3201/eid1907.120932.PMID:23764246

Toolkit for monitoring and evaluation of indoor residual spraying for visceral leishmaniasis control in the Indian subcontinent: application and results.

Huda MM, Mondal D, Kumar V, Das P, Sharma SN, Das ML, Roy L, Gurung CK, Banjara MR, Akhter S, Maheswary NP, Kroeger A, Chowdhury R.

J Trop Med. 2011;2011:876742. doi: 10.1155/2011/876742. Epub 2011 Jul 27.PMID:21811510

 


Insecticide-treated bed nets in rural Bangladesh: their potential role in the visceral leishmaniasis elimination programme.

Mondal D, Chowdhury R, Huda MM, Maheswary NP, Akther S, Petzold M, Kumar V, Das ML, Gurung CK, Ghosh D, Kroeger A.

Trop Med Int Health. 2010 Nov;15(11):1382-9. doi: 10.1111/j.1365-3156.2010.02635.x. Epub 2010 Oct 13.PMID:20946233

Chemical and environmental vector control as a contribution to the elimination of visceral leishmaniasis on the Indian subcontinent: cluster randomized controlled trials in Bangladesh, India and Nepal.

Joshi AB, Das ML, Akhter S, Chowdhury R, Mondal D, Kumar V, Das P, Kroeger A, Boelaert M, Petzold M.

BMC Med. 2009 Oct 5;7:54. doi: 10.1186/1741-7015-7-54.PMID:19804620

Relationship between sand fly fauna and kala-azar endemicity in Bangladesh.

Alam MS, Wagatsuma Y, Mondal D, Khanum H, Haque R.

Acta Trop. 2009 Oct;112(1):23-5. doi: 10.1016/j.actatropica.2009.05.021. Epub 2009 Jun 6.PMID:19501561

Present situation of vector-control management in Bangladesh: a wake up call.

Mondal D, Alam MS, Karim Z, Haque R, Boelaert M, Kroeger A.

Health Policy. 2008 Sep;87(3):369-76. doi: 10.1016/j.healthpol.2008.01.011. Epub 2008 Mar 14.PMID:18342389

User friendliness, efficiency & spray quality of stirrup pumps versus hand compression pumps for indoor residual spraying.

Kumar V, Kesari S, Chowdhury R, Kumar S, Sinha G, Hussain S, Huda MM, Kroeger A, Das P.
Indian J Med Res. 2013;138:239-43.PMID:24056601

Comparison of insecticide-treated nets and indoor residual spraying to control the vector of visceral leishmaniasis in Mymensingh District, Bangladesh.

Chowdhury R, Dotson E, Blackstock AJ, McClintock S, Maheswary NP, Faria S, Islam S, Akter T, Kroeger A, Akhter S, Bern C.
Am J Trop Med Hyg. 2011 May;84(5):662-7. doi: 10.4269/ajtmh.2011.10-0682.PMID:21540372

Factors associated with visceral leishmaniasis in Nepal: bed-net use is strongly protective.

Bern C, Joshi AB, Jha SN, Das ML, Hightower A, Thakur GD, Bista MB.
Am J Trop Med Hyg. 2000 Sep-Oct;63(3-4):184-8.PMID:11388512

Vector control interventions for visceral leishmaniasis elimination initiative in South Asia, 2005-2010.

Picado A, Dash AP, Bhattacharya S, Boelaert M.
Indian J Med Res. 2012 Jul;136(1):22-31. Review.PMID:22885260

Application of RFLP-PCR-Based Identification for Sand Fly Surveillance in an Area Endemic for Kala-Azar in Mymensingh, Bangladesh.

Alam MS, Kato H, Fukushige M, Wagatsuma Y, Itoh M.
J Parasitol Res. 2012;2012:467821. doi: 10.1155/2012/467821. Epub 2012 May 31.PMID:22701164

Relationship between sand fly fauna and kala-azar endemicity in Bangladesh.

Alam MS, Wagatsuma Y, Mondal D, Khanum H, Haque R.
Acta Trop. 2009 Oct;112(1):23-5. doi: 10.1016/j.actatropica.2009.05.021. Epub 2009 Jun 6.PMID:19501561

Visceral leishmaniasis on the Indian sub-continent: a multi-centre study of the costs of three interventions for the control of the sandfly vector, Phlebotomus argentipes.

Das M, Banjara M, Chowdhury R, Kumar V, Rijal S, Joshi A, Akhter S, Das P, Kroeger A.
Ann Trop Med Parasitol. 2008 Dec;102(8):729-41. doi: 10.1179/136485908X355274. PMID:19000390

Vector control by insecticide-treated nets in the fight against visceral leishmaniasis in the Indian subcontinent, what is the evidence?

Ostyn B, Vanlerberghe V, Picado A, Dinesh DS, Sundar S, Chappuis F, Rijal S, Dujardin JC, Coosemans M, Boelaert M, Davies C.
Trop Med Int Health. 2008 Aug;13(8):1073-85. doi: 10.1111/j.1365-3156.2008.02110.x. Epub 2008 Jun 28.PMID:18564350

Long-lasting insecticidal nets fail at household level to reduce abundance of sandfly vector Phlebotomus argentipes in treated houses in Bihar (India).

Dinesh DS, Das P, Picado A, Davies C, Speybroeck N, Ostyn B, Boelaert M, Coosemans M.
Trop Med Int Health. 2008 Jul;13(7):953-8. doi: 10.1111/j.1365-3156.2008.02096.x. Epub 2008 May 8.PMID:18482197
Environment /Climate Change

Virgin soil: the spread of visceral leishmaniasis into Uttar Pradesh, India.

Barnett PG, Singh SP, Bern C, Hightower AW, Sundar S.
Am J Trop Med Hyg. 2005 Oct;73(4):720-5.PMID:16222016
National Kala-azar Elimination Program/ Operational Research

Feasibility of a combined camp approach for vector control together with active case detection of visceral leishmaniasis, post kala-azar dermal leishmaniasis, tuberculosis, leprosy and malaria in Bangladesh, India and Nepal: an exploratory study.

Banjara MR, Kroeger A, Huda MM, Kumar V, Gurung CK, Das ML, Rijal S, Das P, Mondal D.
Trans R Soc Trop Med Hyg. 2015 Jun;109(6):408-15. doi: 10.1093/trstmh/trv031. Epub 2015 Apr 26.PMID: 25918216

How far are we from visceral leishmaniasis elimination in Bangladesh? An assessment of epidemiological surveillance data.

Chowdhury R, Mondal D, Chowdhury V, Faria S, Alvar J, Nabi SG, Boelaert M, Dash AP.
PLoS Negl Trop Dis. 2014 Aug 21;8(8):e3020. doi: 10.1371/journal.pntd.0003020. eCollection 2014 Aug.PMID:25144317

Accelerated active case detection of visceral leishmaniasis patients in endemic villages of Bangladesh.

Khatun J, Huda MM, Hossain MS, Presber W, Ghosh D, Kroeger A, Matlashewski G, Mondal D.
PLoS One. 2014 Aug 4;9(8):e103678. doi: 10.1371/journal.pone.0103678. eCollection 2014. PMID:25090412

Active case detection in national visceral leishmaniasis elimination programs in Bangladesh, India, and Nepal: feasibility, performance and costs.

Huda MM, Hirve S, Siddiqui NA, Malaviya P, Banjara MR, Das P, Kansal S, Gurung CK, Naznin E, Rijal S, Arana B, Kroeger A, Mondal D.
BMC Public Health. 2012 Nov 20;12:1001. doi: 10.1186/1471-2458-12-1001.PMID:23164318

Options for active case detection of visceral leishmaniasis in endemic districts of India, Nepal and Bangladesh, comparing yield, feasibility and costs.

Singh SP, Hirve S, Huda MM, Banjara MR, Kumar N, Mondal D, Sundar S, Das P, Gurung CK, Rijal S, Thakur CP, Varghese B, Kroeger A.
PLoS Negl Trop Dis. 2011 Feb 8;5(2):e960. doi: 10.1371/journal.pntd.0000960.PMID:21347452

Enhanced case detection and improved diagnosis of PKDL in a Kala-azar-endemic area of Bangladesh.

Mondal D, Nasrin KN, Huda MM, Kabir M, Hossain MS, Kroeger A, Thomas T, Haque R.
PLoS Negl Trop Dis. 2010 Oct 5;4(10). pii: e832. doi: 10.1371/journal.pntd.0000832. PMID:20957193

Effectiveness and feasibility of active and passive case detection in the visceral leishmaniasis elimination initiative in India, Bangladesh, and Nepal.

Hirve S, Singh SP, Kumar N, Banjara MR, Das P, Sundar S, Rijal S, Joshi A, Kroeger A, Varghese B, Thakur CP, Huda MM, Mondal D.
Am J Trop Med Hyg. 2010 Sep;83(3):507-11. doi: 10.4269/ajtmh.2010.09-0685 PMID:20810811

Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy.

Mondal D, Singh SP, Kumar N, Joshi A, Sundar S, Das P, Siddhivinayak H, Kroeger A, Boelaert M.
PLoS Negl Trop Dis. 2009;3(1):e355. doi: 10.1371/journal.pntd.0000355. Epub 2009 Jan 13. PMID: 19159009

Leishmaniasis worldwide and global estimates of its incidence.

Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M; WHO Leishmaniasis Control Team.
PLoS One. 2012;7(5):e35671. doi: 10.1371/journal.pone.0035671. Epub 2012 May 31.PMID:22693548

Complexities of assessing the disease burden attributable to leishmaniasis.

Bern C, Maguire JH, Alvar J.
PLoS Negl Trop Dis. 2008;2(10):e313. doi: 10.1371/journal.pntd.0000313. Epub 2008 Oct 29. Review.PMID:18958165

Performance of kala-azar surveillance in Gaffargaon subdistrict of Mymensingh, Bangladesh.

Rahman KM, Samarawickrema IV, Harley D, Olsen A, Butler CD, Sumon SA, Biswas SK, Luby SP, Sleigh AC.
PLoS Negl Trop Dis. 2015 Apr 10;9(4):e0003531. doi: 10.1371/journal.pntd.0003531. eCollection 2015 Apr.PMID:25860258

Visceral leishmaniasis in Nepal during 1980-2006.

Joshi DD, Sharma M, Bhandari S.
J Commun Dis. 2006 Mar;38(2):139-48.PMID:17370676

Can visceral leishmaniasis be eliminated from Asia?

Joshi A, Narain JP, Prasittisuk C, Bhatia R, Hashim G, Jorge A, Banjara M, Kroeger A.
J Vector Borne Dis. 2008 Jun;45(2):105-11. Review.PMID:18592839

Research priorities for elimination of visceral leishmaniasis.

Matlashewski G, Arana B, Kroeger A, Be-Nazir A, Mondal D, Nabi SG, Banjara MR, Das ML, Marasini B, Das P, Medley G, Satoskar A, Nakhasi H, Argaw D, Reeder J, Olliaro P.
Lancet Glob Health. 2014 Dec;2(12):e683-4. doi: 10.1016/S2214-109X(14)70318-3. No abstract available. PMID:25433617

Elimination of visceral leishmaniasis on the Indian subcontinent.

Singh OP, Hasker E, Boelaert M, Sundar S.
Lancet Infect Dis. 2016 Sep 28. pii: S1473-3099(16)30140-2. doi: 10.1016/S1473-3099(16)30140-2. Review.PMID:27692643

Visceral leishmaniasis: elimination with existing interventions.

Matlashewski G, Arana B, Kroeger A, Battacharya S, Sundar S, Das P, Sinha PK, Rijal S, Mondal D, Zilberstein D, Alvar J.
Lancet Infect Dis. 2011 Apr;11(4):322-5. doi: 10.1016/S1473-3099(10)70320-0. Review.PMID:21453873

Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal–the challenges for diagnosis and treatment.

Sundar S, Mondal D, Rijal S, Bhattacharya S, Ghalib H, Kroeger A, Boelaert M, Desjeux P, Richter-Airijoki H, Harms G.
Trop Med Int Health. 2008 Jan;13(1):2-5. doi: 10.1111/j.1365-3156.2007.01974.x. No abstract available. PMID:18290995

Visceral leishmaniasis and its control in Bangladesh.

Elias M, Rahman AJ, Khan NI.
Bull World Health Organ. 1989;67(1):43-9.PMID:2650901

Quantification of the natural history of visceral leishmaniasis and consequences for control.

Chapman LA, Dyson L, Courtenay O, Chowdhury R, Bern C, Medley GF, Hollingsworth TD.
Parasit Vectors. 2015 Oct 22;8:521. doi: 10.1186/s13071-015-1136-3.PMID:26490668

Understanding the transmission dynamics of Leishmania donovani to provide robust evidence for interventions to eliminate visceral leishmaniasis in Bihar, India.

Cameron MM, Acosta-Serrano A, Bern C, Boelaert M, den Boer M, Burza S, Chapman LA, Chaskopoulou A, Coleman M, Courtenay O, Croft S, Das P, Dilger E, Foster G, Garlapati R, Haines L, Harris A, Hemingway J, Hollingsworth TD, Jervis S, Medley G, Miles M, Paine M, Picado A, Poché R, Ready P, Rogers M, Rowland M, Sundar S, de Vlas SJ, Weetman D.
Parasit Vectors. 2016 Jan 27;9:25. doi: 10.1186/s13071-016-1309-8.PMID:26812963

Endemic transmission of visceral leishmaniasis in Bhutan.

Yangzom T, Cruz I, Bern C, Argaw D, den Boer M, Vélez ID, Bhattacharya SK, Molina R, Alvar J.
Am J Trop Med Hyg. 2012 Dec;87(6):1028-37. doi: 10.4269/ajtmh.2012.12-0211. Epub 2012 Oct 22.PMID:23091191

Natural history of a visceral leishmaniasis outbreak in highland Ethiopia.

Herrero M, Orfanos G, Argaw D, Mulugeta A, Aparicio P, Parreño F, Bernal O, Rubens D, Pedraza J, Lima MA, Flevaud L, Palma PP, Bashaye S, Alvar J, Bern C.
Am J Trop Med Hyg. 2009 Sep;81(3):373-7.PMID:19706898

Kala-azar outbreak in Libo Kemkem, Ethiopia: epidemiologic and parasitologic assessment.

Alvar J, Bashaye S, Argaw D, Cruz I, Aparicio P, Kassa A, Orfanos G, Parreño F, Babaniyi O, Gudeta N, Cañavate C, Bern C.
Am J Trop Med Hyg. 2007 Aug;77(2):275-82.PMID:17690399

Health-seeking behaviour, diagnostics and transmission dynamics in the control of visceral leishmaniasis in the Indian subcontinent.

Medley GF, Hollingsworth TD, Olliaro PL, Adams ER.
Nature. 2015 Dec 3;528(7580):S102-8. doi: 10.1038/nature16042.PMID:26633763

Resurgence of visceral leishmaniasis in Bangladesh.

Rahman KM, Islam N.
Bull World Health Organ. 1983;61(1):113-6.PMID:6601534
Bangladesh
Other Articles

RFLPs of ITS, ITS1 and hsp70 amplicons and sequencing of ITS1 of recent clinical isolates of Kala-azar from India and Bangladesh confirms the association of L. tropica with the disease.

Khanra S, Datta S, Mondal D, Saha P, Bandopadhyay SK, Roy S, Manna M.

Acta Trop. 2012 Dec;124(3):229-34. doi: 10.1016/j.actatropica.2012.08.017. Epub 2012 Aug 31.PMID:22960646

Visceral leishmaniasis clinical management in endemic districts of India, Nepal, and bangladesh.

Banjara MR, Hirve S, Siddiqui NA, Kumar N, Kansal S, Huda MM, Das P, Rijal S, Gurung CK, Malaviya P, Arana B, Kroeger A, Mondal D.

J Trop Med. 2012;2012:126093. doi: 10.1155/2012/126093. Epub 2012 May 9. PMID:22649459

How do health care providers deal with kala-azar in the Indian subcontinent?

Kumar N, Singh SP, Mondal D, Joshi A, Das P, Sundar S, Kroeger A, Hirve S, Siddiqui NA, Boelaert M.

Indian J Med Res. 2011 Sep;134:349-55.PMID:21985818

Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells.

Mukhopadhyay R, Mukherjee S, Mukherjee B, Naskar K, Mondal D, Decuypere S, Ostyn B, Prajapati VK, Sundar S, Dujardin JC, Roy S.

Int J Parasitol. 2011 Nov;41(13-14):1311-21. doi: 10.1016/j.ijpara.2011.07.013. Epub 2011 Sep 7.PMID:21920365

Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal–the challenges for diagnosis and treatment.

Sundar S, Mondal D, Rijal S, Bhattacharya S, Ghalib H, Kroeger A, Boelaert M, Desjeux P, Richter-Airijoki H, Harms G.

Trop Med Int Health. 2008 Jan;13(1):2-5. doi: 10.1111/j.1365-3156.2007.01974.x. No abstract available. PMID:18290995

Visceral leishmaniasis-associated mortality in Bangladesh: a retrospective cross-sectional study.

Huda MM, Chowdhury R, Ghosh D, Dash AP, Bhattacharya SK, Mondal D.

BMJ Open. 2014 Jul 22;4(7):e005408. doi: 10.1136/bmjopen-2014-005408.PMID:25052172

Kala-azar in pregnancy in Mymensingh, Bangladesh: a social autopsy.

Rahman KM, Olsen A, Harley D, Butler CD, Mondal D, Luby SP, Sleigh AC.

PLoS Negl Trop Dis. 2014 May 1;8(5):e2710. doi: 10.1371/journal.pntd.0002710. eCollection 2014 May. No abstract available. PMID:24786280

Introducing single dose liposomal amphotericin B for the treatment of visceral leishmaniasis in rural bangladesh: feasibility and acceptance to patients and health staff.

Maintz EM, Hassan M, Huda MM, Ghosh D, Hossain MS, Alim A, Kroeger A, Arana B, Mondal D.

J Trop Med. 2014;2014:676817. doi: 10.1155/2014/676817. Epub 2014 Jan 21.PMID:24578710

Visceral Leishmaniasis Eradication is a Reality: Data from a Community-based Active Surveillance in Bangladesh.

Ferdousi F, Alam MS, Hossain MS, Ma E, Itoh M, Mondal D, Haque R, Wagatsuma Y.

Trop Med Health. 2012 Dec;40(4):133-9. doi: 10.2149/tmh.2012-25. Epub 2012 Dec 22.PMID:23532674

Low prevalence of Leishmania donovani infection among the blood donors in kala-azar endemic areas of Bangladesh.

Huda MM, Rudra S, Ghosh D, Bhaskar KR, Chowdhury R, Dash AP, Bhattacharya SK, Haque R, Mondal D.

BMC Infect Dis. 2013 Feb 2;13:62. doi: 10.1186/1471-2334-13-62.PMID:23375008

Survey of domestic cattle for anti-Leishmania antibodies and Leishmania DNA in a visceral leishmaniasis endemic area of Bangladesh.

Alam MS, Ghosh D, Khan MG, Islam MF, Mondal D, Itoh M, Islam MN, Haque R.

BMC Vet Res. 2011 Jun 8;7:27. doi: 10.1186/1746-6148-7-27. PMID:21651757

The epidemiology of visceral leishmaniasis in Bangladesh: prospects for improved control.

Bern C, Chowdhury R.
Indian J Med Res. 2006 Mar;123(3):275-88. Review.PMID:16778310

The economic impact of visceral leishmaniasis on households in Bangladesh.

Anoopa Sharma D, Bern C, Varghese B, Chowdhury R, Haque R, Ali M, Amann J, Ahluwalia IB, Wagatsuma Y, Breiman RF, Maguire JH, McFarland DA.
Trop Med Int Health. 2006 May;11(5):757-64. Erratum in: Trop Med Int Health. 2006 Sep;11(9):1482. PMID:16640630

Visceral leishmaniasis: consequences to women in a Bangladeshi community.

Ahluwalia IB, Bern C, Wagatsuma Y, Costa C, Chowdhury R, Ali M, Amann J, Haque R, Breiman R, Maguire JH.
J Womens Health (Larchmt). 2004 May;13(4):360-4.PMID:15186651

Visceral leishmaniasis: consequences of a neglected disease in a Bangladeshi community.

Ahluwalia IB, Bern C, Costa C, Akter T, Chowdhury R, Ali M, Alam D, Kenah E, Amann J, Islam M, Wagatsuma Y, Haque R, Breiman RF, Maguire JH.
Am J Trop Med Hyg. 2003 Dec;69(6):624-8.PMID:14740879

Leishmaniasis and poverty.

Alvar J, Yactayo S, Bern C.
Trends Parasitol. 2006 Dec;22(12):552-7. Epub 2006 Oct 4.PMID:17023215

Human resource assessment for scaling up VL active case detection in Bangladesh, India and Nepal.

Naznin E, Kroeger A, Siddiqui NA, Sundar S, Malaviya P, Mondal D, Huda MM, Das P, Karki P, Banjara MR, Dreesch N, Gedik G.
Trop Med Int Health. 2013 Jun;18(6):734-42. doi: 10.1111/tmi.12124. Epub 2013 May 8.PMID:23651494

Visceral Leishmaniasis Eradication is a Reality: Data from a Community-based Active Surveillance in Bangladesh.

Ferdousi F, Alam MS, Hossain MS, Ma E, Itoh M, Mondal D, Haque R, Wagatsuma Y.
Trop Med Health. 2012 Dec;40(4):133-9. doi: 10.2149/tmh.2012-25. Epub 2012 Dec 22.PMID:23532674

Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control.

Stauch A, Sarkar RR, Picado A, Ostyn B, Sundar S, Rijal S, Boelaert M, Dujardin JC, Duerr HP.
PLoS Negl Trop Dis. 2011 Nov;5(11):e1405. doi: 10.1371/journal.pntd.0001405. Epub 2011 Nov 29.PMID:22140589

Survey of domestic cattle for anti-Leishmania antibodies and Leishmania DNA in a visceral leishmaniasis endemic area of Bangladesh.

Alam MS, Ghosh D, Khan MG, Islam MF, Mondal D, Itoh M, Islam MN, Haque R.
BMC Vet Res. 2011 Jun 8;7:27. doi: 10.1186/1746-6148-7-27.PMID:21651757

Kala azar in Pregnancy.

Miah MT, Ayaz FM, Maniruzzaman M, Ahasan MN, Bari S, Mawla SM, Mahbub MS, Khan AI.
Mymensingh Med J. 2010 Oct;19(4):529-32.PMID:20956894

A cost benefit analysis of elimination of kala-azar in Indian subcontinent: an example of Nepal.

Adhikari SR, Supakankunti S.
J Vector Borne Dis. 2010 Sep;47(3):127-39.PMID:20834081

Cutaneous leishmaniasis.

Ahmed Z, Chowdhury SA, Bhuiyan SI.
Mymensingh Med J. 2009 Jul;18(2):260-3.PMID:19623158

Relationship between sand fly fauna and kala-azar endemicity in Bangladesh.

Alam MS, Wagatsuma Y, Mondal D, Khanum H, Haque R.
Acta Trop. 2009 Oct;112(1):23-5. doi: 10.1016/j.actatropica.2009.05.021. Epub 2009 Jun 6.PMID:19501561

Epidemiological characteristics of sixty five cases of Kala-azar attending to a laboratory in Mymensingh.

Talukder SI, Huq MH, Rahman S, Haque MA, Sarker CB, Ali MS.
Mymensingh Med J. 2003 Jul;12(2):89-92.PMID:12894039

Clinical profile of Kala-azar in adults: as seen in Mymensingh Medical College Hospital, Mymensingh, Bangladesh.

Sarker CB, Chowdhury KS, Siddiqui NI, Jamal MF, Rahman S, Momen A, Dhar DK, Alam KS.
Mymensingh Med J. 2003 Jan;12(1):41-4.PMID:12715642

Characterisation of Bangladeshi Leishmania isolated from kala-azar patients by isoenzyme electrophoresis.

Shamsuzzaman SM, Furuya M, Shamsuzzaman Choudhury AK, Korenaga M, Hashiguchi Y.
Parasitol Int. 2000 Aug;49(2):139-45.PMID:10882903

Epidemiology of visceral leishmaniasis in India.

Bora D.
Natl Med J India. 1999 Mar-Apr;12(2):62-8. Review.
PMID:10416321
Conference Abstract/Paper
Epidemiology

Disease Burden/ Trend

 

Risk factors

Risk factors for kala-azar in Bangladesh.

Bern C, Hightower AW, Chowdhury R, Ali M, Amann J, Wagatsuma Y, Haque R, Kurkjian K, Vaz LE, Begum M, Akter T, Cetre-Sossah CB, Ahluwalia IB, Dotson E, Secor WE, Breiman RF, Maguire JH.
Emerg Infect Dis. 2005 May;11(5):655-62.PMID:15890115

Risk factors for visceral Leishmaniasis among residents and migrants in Kafta-Humera, Ethiopia.

Argaw D, Mulugeta A, Herrero M, Nombela N, Teklu T, Tefera T, Belew Z, Alvar J, Bern C.
PLoS Negl Trop Dis. 2013 Nov 7;7(11):e2543. doi: 10.1371/journal.pntd.0002543. eCollection 2013 Nov.PMID:24244778

Of cattle, sand flies and men: a systematic review of risk factor analyses for South Asian visceral leishmaniasis and implications for elimination.

Bern C, Courtenay O, Alvar J.
PLoS Negl Trop Dis. 2010 Feb 9;4(2):e599. doi: 10.1371/journal.pntd.0000599. Review. Erratum in: PLoS Negl Trop Dis. 2010;4(3). doi: 10.1371/annotation/f96dd2ce-05de-4aa5-a9d5-c481b0745c84. PMID:20161727

Risk factors for visceral leishmaniasis in a new epidemic site in Amhara Region, Ethiopia.

Bashaye S, Nombela N, Argaw D, Mulugeta A, Herrero M, Nieto J, Chicharro C, Cañavate C, Aparicio P, Vélez ID, Alvar J, Bern C.
Am J Trop Med Hyg. 2009 Jul;81(1):34-9.PMID:19556563

Visceral leishmaniasis: adult population of Abbottabad at risk now.

Idris M, Farid J, Gul N, Anis-ur-Rehman.
J Ayub Med Coll Abbottabad. 2010 Apr-Jun;22(2):214-5.PMID:21702307

Epidemiological study of risk factors related to childhood visceral leishmaniasis.

Rukunuzzaman M, Rahman M.
Mymensingh Med J. 2008 Jan;17(1):46-50.PMID:18285731

Asymptomatic VL

The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village.

Bern C, Haque R, Chowdhury R, Ali M, Kurkjian KM, Vaz L, Amann J, Wahed MA, Wagatsuma Y, Breiman RF, Williamson J, Secor WE, Maguire JH.
Am J Trop Med Hyg. 2007 May;76(5):909-14.PMID:17488915

Co-infection

First case of pulmonary tuberculosis and visceral leishmaniasis coinfection successfully treated with antituberculosis drug and liposomal amphotericin B.

Hasnain MG, Ghosh P, Sharafat Sonin MS, Baker J, Mondal D.

Clin Case Rep. 2014 Dec;2(6):331-2. doi: 10.1002/ccr3.130. Epub 2014 Sep 4.PMID: 25548640

Transmission Dynamics/ Outbreak

 

Post Kala-azar Dermal Leishmanisis (PKDL)

Post-Kala-Azar Dermal Leishmaniasis without Previous History of Visceral Leishmaniasis.

Hasnain MG, Shomik MS, Ghosh P, Rashid MO, Hossain MS, Hamano S, Mondal D.
Am J Trop Med Hyg. 2016 Sep 26. pii: 16-0230. [Epub ahead of print] PMID:27672208

A Comparison of the Effectiveness of Sodium Stibogluconate Monotherapy to Sodium Stibogluconate and Paromomycin Combination for the Treatment of Severe Post Kala Azar Dermal Leishmaniasis in South Sudan – A Retrospective Cohort Study.

Abongomera C, Gatluak F, Buyze J, Ritmeijer K.
PLoS One. 2016 Sep 22;11(9):e0163047. doi: 10.1371/journal.pone.0163047. eCollection 2016. PMID: 27658288

Clinical and immunological aspects of post-kala-azar dermal leishmaniasis in Bangladesh.

Islam S, Kenah E, Bhuiyan MA, Rahman KM, Goodhew B, Ghalib CM, Zahid MM, Ozaki M, Rahman MW, Haque R, Luby SP, Maguire JH, Martin D, Bern C.
Am J Trop Med Hyg. 2013 Aug;89(2):345-53. doi: 10.4269/ajtmh.12-0711. Epub 2013 Jul 1.PMID:23817330

Economic consequences of post-kala-azar dermal leishmaniasis in a rural Bangladeshi community.

Ozaki M, Islam S, Rahman KM, Rahman A, Luby SP, Bern C.
Am J Trop Med Hyg. 2011 Sep;85(3):528-34. doi: 10.4269/ajtmh.2011.10-0683.

PMID:21896817


Post-Kala-Azar dermal leishmaniasis in Mymensingh, Bangladesh.

Islam S, Ashraful Alam Bhuiyan M, Bern C.
Am J Trop Med Hyg. 2011 Aug;85(2):193-4. doi: 10.4269/ajtmh.2011.11-0128. No abstract available. PMID:21813832

Increasing incidence of post-kala-azar dermal leishmaniasis in a population-based study in Bangladesh.

Rahman KM, Islam S, Rahman MW, Kenah E, Ghalib CM, Zahid MM, Maguire J, Rahman M, Haque R, Luby SP, Bern C.
Clin Infect Dis. 2010 Jan 1;50(1):73-6. doi: 10.1086/648727. Erratum in: Clin Infect Dis. 2010 May 1;50(9):1329. Galive, Chowdhury Mohammad [corrected to Ghalib, Chowdhury Mohammad]. PMID:19951168

Study on the safety and efficacy of miltefosine for the treatment of children and adolescents with post-kala-azar dermal leishmaniasis in Bangladesh, and an association of serum vitamin E and exposure to arsenic with post-kala-azar dermal leishmaniasis: an open clinical trial and case-control study protocol.

Mondal D, Hasnain MG, Hossain MS, Ghosh D, Ghosh P, Hossain H, Baker J, Nath R, Haque R, Matlashewski G, Hamano S.
BMJ Open. 2016 May 17;6(5):e010050. doi: 10.1136/bmjopen-2015-010050. PMID:27188804

A Study on Health Seeking Behaviors of Patients of Post-Kala-Azar Dermal Leishmaniasis.

Basher A, Nath P, Nabi SG, Selim S, Rahman MF, Sutradhar SR, Faiz A, Bhuiyan MR, Ahmed BN, Rahman R.
Biomed Res Int. 2015;2015:314543. doi: 10.1155/2015/314543.PMID:26788500

Decreased presence of Langerhans cells is a critical determinant for Indian Post kala-azar dermal leishmaniasis.

Mukherjee S, Mukhopadhyay D, Braun C, Barbhuiya JN, Das NK, Chatterjee U, von Stebut E, Chatterjee M.
Exp Dermatol. 2015 Mar;24(3):232-4. doi: 10.1111/exd.12635.PMID:25580856

Post-Kala-azar dermal leishmaniasis ( a review of 10 cases).

Khan HM.
Bangladesh Med Res Counc Bull. 1977 Dec;3(2):130-6.PMID:615589
Diagnosis

Visceral leishmaniasis (VL)

Evaluation of diagnostic performance of rK28 ELISA using urine for diagnosis of visceral leishmaniasis.

Ghosh P, Bhaskar KR, Hossain F, Khan MA, Vallur AC, Duthie MS, Hamano S, Salam MA, Huda MM, Khan MG, Coler RN, Reed SG, Mondal D.
Parasit Vectors. 2016 Jul 4;9(1):383. doi: 10.1186/s13071-016-1667-2.PMID:27377266

Mobile suitcase laboratory for rapid detection of Leishmania donovani using recombinase polymerase amplification assay.

Mondal D, Ghosh P, Khan MA, Hossain F, Böhlken-Fascher S, Matlashewski G, Kroeger A, Olliaro P, Abd El Wahed A.
Parasit Vectors. 2016 May 13;9(1):281. doi: 10.1186/s13071-016-1572-8.PMID:27177926

Accurate Serodetection of Asymptomatic Leishmania donovani Infection by Use of Defined Antigens.

Vallur AC, Reinhart C, Mohamath R, Goto Y, Ghosh P, Mondal D, Duthie MS, Reed SG.
J Clin Microbiol. 2016 Apr;54(4):1025-30. doi: 10.1128/JCM.02620-15. Epub 2016 Feb 3.PMID:26842701

Polymerase Chain Reaction in the Diagnosis of Visceral Leishmaniasis Recurrence in the Setting of Negative Splenic Smears.

Hasnain G, Basher A, Nath P, Ghosh P, Hossain F, Hossain S, Mondal D.
Am J Trop Med Hyg. 2016 Jan;94(1):99-101. doi: 10.4269/ajtmh.15-0136. Epub 2015 Nov 10.PMID: 26556834

Development and comparative evaluation of two antigen detection tests for Visceral Leishmaniasis.

Vallur AC, Tutterrow YL, Mohamath R, Pattabhi S, Hailu A, Abdoun AO, Ahmed AE, Mukhtar M, Salam MA, Almeida ML, Almeida RP, Mondal D, Albertini A, Ghalib H, Duthie MS, Reed SG.
BMC Infect Dis. 2015 Sep 22;15:384. doi: 10.1186/s12879-015-1125-3.PMID:26395447

A comparative evaluation of the performance of commercially available rapid immunochromatographic tests for the diagnosis of visceral leishmaniasis in Bangladesh.

Ghosh P, Hasnain MG, Ghosh D, Hossain F, Baker J, Boelaert M, Rijal S, Mondal D.
Parasit Vectors. 2015 Jun 16;8:331. doi: 10.1186/s13071-015-0935-x.PMID:26077956

An evaluation of the performance of direct agglutination test on filter paper blood sample for the diagnosis of visceral leishmaniasis.

Hasnain MG, Ghosh P, Baker J, Mondal D.
Am J Trop Med Hyg. 2014 Aug;91(2):342-4. doi: 10.4269/ajtmh.13-0530. Epub 2014 Jun 23.PMID:24957542

Comparison of PCR-based diagnoses for visceral leishmaniasis in Bangladesh.

Khan MG, Bhaskar KR, Kikuchi M, Salam MA, Akther T, Haque R, Mondal D, Hamano S.
Parasitol Int. 2014 Apr;63(2):327-31. doi: 10.1016/j.parint.2013.12.001. Epub 2013 Dec 12.PMID:24333754

Diagnostic accuracy of loop-mediated isothermal amplification (LAMP) for detection of Leishmania DNA in buffy coat from visceral leishmaniasis patients.

Khan MG, Bhaskar KR, Salam MA, Akther T, Pluschke G, Mondal D.
Parasit Vectors. 2012 Dec 3;5:280. doi: 10.1186/1756-3305-5-280.PMID:23206441

Characterization of the recent clinical isolates of Indian Kala-azar patients by RAPD-PCR method.

Khanra S, Bandopadhyay SK, Chakraborty P, Datta S, Mondal D, Chatterjee M, Naskar K, Roy S, Manna M.
J Parasit Dis. 2011 Oct;35(2):116-22. Epub 2011 Jun 24.PMID:23024491

A global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasis.

Cunningham J, Hasker E, Das P, El Safi S, Goto H, Mondal D, Mbuchi M, Mukhtar M, Rabello A, Rijal S, Sundar S, Wasunna M, Adams E, Menten J, Peeling R, Boelaert M; WHO/TDR Visceral Leishmaniasis Laboratory Network.
Clin Infect Dis. 2012 Nov 15;55(10):1312-9. doi: 10.1093/cid/cis716. Epub 2012 Aug 31.PMID:22942208

Peripheral blood buffy coat smear: a promising tool for diagnosis of visceral leishmaniasis.

Salam MA, Khan MG, Bhaskar KR, Afrad MH, Huda MM, Mondal D.
J Clin Microbiol. 2012 Mar;50(3):837-40. doi: 10.1128/JCM.05067-11. Epub 2012 Jan 11.PMID:22205790

Design, development and evaluation of rK28-based point-of-care tests for improving rapid diagnosis of visceral leishmaniasis.

Pattabhi S, Whittle J, Mohamath R, El-Safi S, Moulton GG, Guderian JA, Colombara D, Abdoon AO, Mukhtar MM, Mondal D, Esfandiari J, Kumar S, Chun P, Reed SG, Bhatia A.
PLoS Negl Trop Dis. 2010 Sep 14;4(9). pii: e822. doi: 10.1371/journal.pntd.0000822. PMID:20856856

Loss of leishmanin skin test antigen sensitivity and potency in a longitudinal study of visceral leishmaniasis in Bangladesh.

Bern C, Amann J, Haque R, Chowdhury R, Ali M, Kurkjian KM, Vaz L, Wagatsuma Y, Breiman RF, Secor WE, Maguire JH.
Am J Trop Med Hyg. 2006 Oct;75(4):744-8.PMID:17038705

Evaluation of two rK39 dipstick tests, direct agglutination test, and indirect fluorescent antibody test for diagnosis of visceral leishmaniasis in a new epidemic site in highland Ethiopia.

Cañavate C, Herrero M, Nieto J, Cruz I, Chicharro C, Aparicio P, Mulugeta A, Argaw D, Blackstock AJ, Alvar J, Bern C.
Am J Trop Med Hyg. 2011 Jan;84(1):102-6. doi: 10.4269/ajtmh.2011.10-0229.PMID:21212210

Multiplex analysis of circulating cytokines in the sera of patients with different clinical forms of visceral leishmaniasis.

Kurkjian KM, Mahmutovic AJ, Kellar KL, Haque R, Bern C, Secor WE.
Cytometry A. 2006 May;69(5):353-8.PMID:16604536

Application of an improved method for the recombinant k 39 enzyme-linked immunosorbent assay to detect visceral leishmaniasis disease and infection in Bangladesh.

Kurkjian KM, Vaz LE, Haque R, Cetre-Sossah C, Akhter S, Roy S, Steurer F, Amann J, Ali M, Chowdhury R, Wagatsuma Y, Williamson J, Crawford S, Breiman RF, Maguire JH, Bern C, Secor WE.
Clin Diagn Lab Immunol. 2005 Dec;12(12):1410-5.PMID:16339064

Use of the recombinant K39 dipstick test and the direct agglutination test in a setting endemic for visceral leishmaniasis in Nepal.

Bern C, Jha SN, Joshi AB, Thakur GD, Bista MB.
Am J Trop Med Hyg. 2000 Sep-Oct;63(3-4):153-7.PMID:11388508

PCR-based detection of Leishmania donovani DNA in a stray dog from a visceral Leishmaniasis endemic focus in Bangladesh.

Alam MZ, Yasin G, Kato H, Sakurai T, Katakura K.
J Vet Med Sci. 2013 Jan 31;75(1):75-8. Epub 2012 Aug 10.PMID:22878541

ELISA with recombinant rKRP42 antigen using urine samples: a tool for predicting clinical visceral leishmaniasis cases and its outbreak.

Islam MZ, Itoh M, Ul Islam MA, Saifuddin Ekram AR, Rahman MA, Takagi H, Takesue A, Hashiguchi Y, Kimura E.
Am J Trop Med Hyg. 2012 Oct;87(4):658-62. doi: 10.4269/ajtmh.2012.12-0168. Epub 2012 Aug 6.PMID:22869633

Spectrum of skin lesions of post-kala-azar dermal leishmaniasis in kala-azar endemic areas of Bangladesh.

Sultana A, Zakaria SM, Bhuiyan SI, Habib A, Dey SK, Rahman M, Basher A.
Mymensingh Med J. 2012 Jul;21(3):529-32.PMID:22828555

PCR-based detection of Leishmania DNA in skin samples of post kala-azar dermal leishmaniasis patients from an endemic area of Bangladesh.

Nasreen SA, Hossain MA, Paul SK, Mahmud MC, Ahmed S, Ghosh S, Kobayashi N.
Jpn J Infect Dis. 2012 Jul;65(4):315-7.PMID:22814154

Short communication: evaluation of a new rapid diagnostic test for quality assurance by kala azar elimination programme in bangladesh.

Khan MG, Alam MS, Bhuiyan AT, Jamil MA, Saha B, Islam M, Haque R, Hossain M, Jamil KM.
J Parasitol Res. 2011;2011:862475. doi: 10.1155/2011/862475. Epub 2011 Nov 2. PMID:22132308

Evaluation of rK-39 strip test using urine for diagnosis of visceral leishmaniasis in an endemic area in Bangladesh.

Khan MG, Alam MS, Podder MP, Itoh M, Jamil KM, Haque R, Wagatsuma Y.
Parasit Vectors. 2010 Nov 26;3:114. doi: 10.1186/1756-3305-3-114. PMID:21110875

Sensitivity, specificity and predictive values of immunochromatographic strip test in diagnosis of childhood kala-azar.

Rouf MA, Rahman ME, Islam MN, Islam MN, Ferdous NN, Hossain MA.
Mymensingh Med J. 2009 Jan;18(1 Suppl):S1-5.PMID:19377416

Antigen detection from urine of Kala-azar cases by latex agglutination test.

Alam M, Shamsuzzaman A, Musa A, Khan A, Mahmud M, Hossain M, Ahmed A.
Mymensingh Med J. 2008 Jan;17(1):22-7.PMID:18285726

Diagnostic efficacy of Aldehyde test in late cases of Kala-azar.

Parvin R, Rahman ME, Islam MN, Uddin SN, Khaleque MA, Choudhury AM.
Mymensingh Med J. 2007 Jul;16(2):160-4.PMID:17703152

Sensitivity of splenic and bone marrow aspirate study for diagnosis of kala-azar.

Sarker CB, Alam KS, Jamal MF, Rahman S, Huq MH, Musa AK, Sutradhar SR, Talukder SI, Debnath CR.
Mymensingh Med J. 2004 Jul;13(2):130-3.PMID:15284686

Immunochromatographic (rK39) strip test in the diagnosis of visceral leishmaniasis in Bangladesh.

Sarker CB, Momen A, Jamal MF, Siddiqui NI, Siddiqui FM, Chowdhury KS, Rahman S, Talukder SI.
Mymensingh Med J. 2003 Jul;12(2):93-7.PMID:12894040

Comparative studies on IFAT, ELISA & DAT for serodiagnosis of visceral leishmaniasis in Bangladesh.

Alam MJ, Rahman KM, Asna SM, Muazzam N, Ahmed I, Chowdhury MZ.
Bangladesh Med Res Counc Bull. 1996 Apr;22(1):27-32.PMID:9037842

Evaluation of cleaving agents other than trypsin in direct agglutination test for further improving diagnosis of visceral leishmaniasis.

el Harith A, Chowdhury S, al-Masum A, Semião-Santos S, Karim E, el-Safi S, Haque I.
J Clin Microbiol. 1995 Aug;33(8):1984-8.PMID:7559934

Characterization of Leishmania isolated from patients with kala-azar and post kala-azar dermal leishmaniasis in Bangladesh.

el-Masum MA, Evans DA.
Trans R Soc Trop Med Hyg. 1995 May-Jun;89(3):331-2. No abstract available. PMID:7660453

Visceral leishmaniasis in Bangladesh: the value of DAT as a diagnostic tool.

el-Masum MA, Evans DA, Minter DM, el Harith A.
Trans R Soc Trop Med Hyg. 1995 Mar-Apr;89(2):185-6.PMID:7778144

Agglutinating anti-leishmanial antibodies in the saliva of kala-azar patients.

Masum MA, Evans DA.
Trans R Soc Trop Med Hyg. 1994 Nov-Dec;88(6):660. No abstract available. PMID:7886762

Applicability of direct agglutination test (DAT) at a rural health setting in Bangladesh and feasibility of local antigen production.

Chowdhury MS, al Masum A, al Karim E, Semiáo-Santos S, Rahman KM, Ar-Rashid H, el Harith A.
Arch Inst Pasteur Tunis. 1993 Jul-Oct;70(3-4):333-44.PMID:7802488

Prevalence of agglutinating anti-Leishmania antibodies in two multi-thousand Bengoli communities.

Chowdhury MS, el Harith A, al Massum A, al Karim E, al Rahman A.
Parasitol Res. 1993;79(6):444-50.PMID:8415555

Indirect fluorescent antibody test in the serodiagnosis of visceral leishmaniasis in Bangladesh.

Muazzam N, Rahman KM, Miah RA, Asna SM.
Bangladesh Med Res Counc Bull. 1992 Dec;18(2):77-81.PMID:1303085

Aldehyde test (Formol-Gel test) in the diagnosis of kala-azar (visceral leishmaniasis).

Chowdhury MA, Rafiqueuddin AK, Hussain A.
Trop Doct. 1992 Oct;22(4):185-6. No abstract available. PMID:1440905

Relapse/Treatment Failure VL

Post Kala-azar Dermal Leishmaniasis

Treatment

Visceral leishmaniasis (VL)

Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, North-West Ethiopia.

Tamiru A, Tigabu B, Yifru S, Diro E, Hailu A.
BMC Infect Dis. 2016 Oct 10;16(1):548.PMID:27724891

Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial.

Wasunna M, Njenga S, Balasegaram M, Alexander N, Omollo R, Edwards T, Dorlo TP, Musa B, Ali MH, Elamin MY, Kirigi G, Juma R, Kip AE, Schoone GJ, Hailu A, Olobo J, Ellis S, Kimutai R, Wells S, Khalil EA, Strub Wourgaft N, Alves F, Musa A.
PLoS Negl Trop Dis. 2016 Sep 14;10(9):e0004880. doi: 10.1371/journal.pntd.0004880. eCollection 2016 Sep. PMID:27627654

 

Relapse/Treatment Failure VL

Efficacy and safety of single-dose liposomal amphotericin B for visceral leishmaniasis in a rural public hospital in Bangladesh: a feasibility study.

Mondal D, Alvar J, Hasnain MG, Hossain MS, Ghosh D, Huda MM, Nabi SG, Sundar S, Matlashewski G, Arana B.
Lancet Glob Health. 2014 Jan;2(1):e51-7. doi: 10.1016/S2214-109X(13)70118-9. Epub 2013 Dec 5.PMID:25104636

Liposomal amphotericin B for the treatment of visceral leishmaniasis.

Bern C, Adler-Moore J, Berenguer J, Boelaert M, den Boer M, Davidson RN, Figueras C, Gradoni L, Kafetzis DA, Ritmeijer K, Rosenthal E, Royce C, Russo R, Sundar S, Alvar J.
Clin Infect Dis. 2006 Oct 1;43(7):917-24. Epub 2006 Aug 28.PMID:16941377

Post Kala-azar Dermal Leishmaniasis

Effectiveness Study of Paromomycin IM Injection (PMIM) for the Treatment of Visceral Leishmaniasis (VL) in Bangladesh.

Jamil KM, Haque R, Rahman R, Faiz MA, Bhuiyan AT, Kumar A, Hassan SM, Kelly H, Dhalaria P, Kochhar S, Desjeux P, Bhuiyan MA, Khan MM, Ghosh RS.
PLoS Negl Trop Dis. 2015 Oct 23;9(10):e0004118. doi: 10.1371/journal.pntd.0004118. eCollection 2015.PMID:26496648

Effectiveness and safety of short course liposomal amphotericin B (AmBisome) as first line treatment for visceral leishmaniasis in Bangladesh.

Lucero E, Collin SM, Gomes S, Akter F, Asad A, Kumar Das A, Ritmeijer K.
PLoS Negl Trop Dis. 2015 Apr 2;9(4):e0003699. doi: 10.1371/journal.pntd.0003699. eCollection 2015 Apr.PMID:25837313

Miltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendations.

Monge-Maillo B, López-Vélez R.
Clin Infect Dis. 2015 May 1;60(9):1398-404. doi: 10.1093/cid/civ004. Epub 2015 Jan 18. Review.PMID:25601455

Specific antibody responses as indicators of treatment efficacy for visceral leishmaniasis.

Vallur AC, Hailu A, Mondal D, Reinhart C, Wondimu H, Tutterrow Y, Ghalib HW, Reed SG, Duthie MS.
Eur J Clin Microbiol Infect Dis. 2015 Apr;34(4):679-86. doi: 10.1007/s10096-014-2282-9. Epub 2014 Nov 19.PMID:25407374

Drug combinations for visceral leishmaniasis.

Olliaro PL.
Curr Opin Infect Dis. 2010 Dec;23(6):595-602. doi: 10.1097/QCO.0b013e32833fca9d. Review.PMID:20871400

Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent.

Meheus F, Balasegaram M, Olliaro P, Sundar S, Rijal S, Faiz MA, Boelaert M.
PLoS Negl Trop Dis. 2010 Sep 7;4(9). pii: e818. doi: 10.1371/journal.pntd.0000818. PMID:20838649

Barriers to treatment for visceral leishmaniasis in hyperendemic areas: India, Bangladesh, Nepal, Brazil and Sudan.

Thornton SJ, Wasan KM, Piecuch A, Lynd LL, Wasan EK.
Drug Dev Ind Pharm. 2010 Nov;36(11):1312-9. doi: 10.3109/03639041003796648. Review.PMID:20545513

Sodium stibogluconate-sensitive visceral leishmaniasis in the non-endemic hilly region of Uttarakhand, India.

Verma SK, Ahmad S, Shirazi N, Kusum A, Kaushik RM, Barthwal SP.
Trans R Soc Trop Med Hyg. 2007 Jul;101(7):730-2. Epub 2007 Mar 23.
PMID:17382981

Drug resistance mechanisms in clinical isolates of Leishmania donovani.

Singh N.
Indian J Med Res. 2006 Mar;123(3):411-22. Review.PMID:16778320

Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980-2004.

Olliaro PL, Guerin PJ, Gerstl S, Haaskjold AA, Rottingen JA, Sundar S.
Lancet Infect Dis. 2005 Dec;5(12):763-74. Review.PMID:16310148

Progress in the treatment of a neglected infectious disease: visceral leishmaniasis.

Murray HW.
Expert Rev Anti Infect Ther. 2004 Apr;2(2):279-92. Review. Erratum in: Expert Rev Anti Infect Ther. 2004 Jun;2(3):462. PMID:15482193

Deaths in visceral leishmaniasis (Kala-azar) during treatment.

Ahasan HA, Chowdhury MA, Azhar MA, Rafiqueuddin AK, Azad KA.
Med J Malaysia. 1996 Mar;51(1):29-32.PMID:10967976

Does antimony therapy cause bleeding in kala-azar patients and why?

Chowdhury MA, Ahasan HA, Azhar MA, Rafiqueuddin AK, Islam MR, Misbahuddin M, Rashid MU.
Trop Doct. 1995 Oct;25(4):188-9. No abstract available. PMID:7502336
Case Report

Cutaneous leishmaniasis in an immigrant Saudi worker: a case report.

Rahman H, Razzak MA, Chanda BC, Bhaskar KR, Mondal D.

J Health Popul Nutr. 2014 Jun;32(2):372-6.PMID:25076674

Post-kala-azar dermal leishmaniasis with mucosal involvement: an unusual case presentation including successful treatment with miltefosine.

Salam MA, Siddiqui MA, Nabi SG, Bhaskar KR, Mondal D.

J Health Popul Nutr. 2013 Jun;31(2):294-7.PMID:23930349

A poor-quality generic drug for the treatment of visceral leishmaniasis: a case report and appeal.

Dorlo TP, Eggelte TA, Schoone GJ, de Vries PJ, Beijnen JH.
PLoS Negl Trop Dis. 2012;6(5):e1544. doi: 10.1371/journal.pntd.0001544. Epub 2012 May 29. No abstract available. PMID:22666507

A case of kala-azar diagnosed by bone marrow aspiration.

Hamidah NH, Cheong SK, Abu Hassan J.
Malays J Pathol. 1995 Jun;17(1):39-41.PMID:8907004

An historical review of malaria, kala-azar and filariasis in Bangladesh in relation to the Flood Action Plan.

Birley MH.
Ann Trop Med Parasitol. 1993 Aug;87(4):319-34. Review.PMID:8250623

Unusual features in kala-azar: a case report.

Chowdhury AH, Islam N.
Bangladesh Med Res Counc Bull. 1986 Dec;12(2):99-104. No abstract available.PMID:3566688
Review Article

Elimination of visceral leishmaniasis on the Indian subcontinent.

Singh OP, Hasker E, Boelaert M, Sundar S.

Lancet Infect Dis. 2016 Sep 28. pii: S1473-3099(16)30140-2. doi: 10.1016/S1473-3099(16)30140-2. Review.PMID:27692643

Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent – A Systematic Literature Review.

Hirve S, Boelaert M, Matlashewski G, Mondal D, Arana B, Kroeger A, Olliaro P.

PLoS Negl Trop Dis. 2016 Aug 4;10(8):e0004896. doi: 10.1371/journal.pntd.0004896. eCollection 2016 Aug. PMID: 27490264


Research priorities for elimination of visceral leishmaniasis.

Matlashewski G, Arana B, Kroeger A, Be-Nazir A, Mondal D, Nabi SG, Banjara MR, Das ML, Marasini B, Das P, Medley G, Satoskar A, Nakhasi H, Argaw D, Reeder J, Olliaro P.

Lancet Glob Health. 2014 Dec;2(12):e683-4. doi: 10.1016/S2214-109X(14)70318-3. No abstract available. PMID:25433617

Recent advances in post-kala-azar dermal leishmaniasis.

Mondal D, Khan MG.

Curr Opin Infect Dis. 2011 Oct;24(5):418-22. doi: 10.1097/QCO.0b013e32834a8ba1. Review.PMID:21885919

Visceral leishmaniasis: elimination with existing interventions.

Matlashewski G, Arana B, Kroeger A, Battacharya S, Sundar S, Das P, Sinha PK, Rijal S, Mondal D, Zilberstein D, Alvar J.

Lancet Infect Dis. 2011 Apr;11(4):322-5. doi: 10.1016/S1473-3099(10)70320-0. Review.PMID:21453873

Complexities of assessing the disease burden attributable to leishmaniasis.

Bern C, Maguire JH, Alvar J.
PLoS Negl Trop Dis. 2008;2(10):e313. doi: 10.1371/journal.pntd.0000313. Epub 2008 Oct 29. Review.PMID:18958165

Recent advances in the diagnosis and treatment of kala-azar.

Sundar S, Chakravarty J.
Natl Med J India. 2012 Mar-Apr;25(2):85-9. Review.PMID:22686715
Drug Development
Vaccine

From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE.

Coler RN, Duthie MS, Hofmeyer KA, Guderian J, Jayashankar L, Vergara J, Rolf T, Misquith A, Laurance JD, Raman VS, Bailor HR, Cauwelaert ND, Reed SJ, Vallur A, Favila M, Orr MT, Ashman J, Ghosh P, Mondal D, Reed SG.

Clin Transl Immunology. 2015 Apr 10;4(4):e35. doi: 10.1038/cti.2015.6. eCollection 2015 Apr.PMID:26175894

Leishmaniasis vaccine candidates for development: a global overview.

Khamesipour A, Rafati S, Davoudi N, Maboudi F, Modabber F.
Indian J Med Res. 2006 Mar;123(3):423-38. Review.PMID:16778321
Genetics & Leishmaniasis
Vector Control / Entomology

Entomological efficacy of durable wall lining with reduced wall surface coverage for strengthening visceral leishmaniasis vector control in Bangladesh, India and Nepal.

Huda MM, Kumar V, Das ML, Ghosh D, Priyanka J, Das P, Alim A, Matlashewski G, Kroeger A, Alfonso-Sierra E, Mondal D.

BMC Infect Dis. 2016 Oct 6;16(1):539.PMID: 27716091

Efficacy, Safety and Cost of Insecticide Treated Wall Lining, Insecticide Treated Bed Nets and Indoor Wall Wash with Lime for Visceral Leishmaniasis Vector Control in the Indian Sub-continent: A Multi-country Cluster Randomized Controlled Trial.

Mondal D, Das ML, Kumar V, Huda MM, Das P, Ghosh D, Priyanka J, Matlashewski G, Kroeger A, Upfill-Brown A, Chowdhury R.

PLoS Negl Trop Dis. 2016 Aug 17;10(8):e0004932. doi: 10.1371/journal.pntd.0004932. eCollection 2016 Aug. PMID: 27533097

Implication of vector characteristics of Phlebotomus argentipes in the kala-azar elimination programme in the Indian sub-continent.

Chowdhury R, Kumar V, Mondal D, Das ML, Das P, Dash AP, Kroeger A.

Pathog Glob Health. 2016 May;110(3):87-96. doi: 10.1080/20477724.2016.1180775.PMID: 27376500

Reducing visceral leishmaniasis by insecticide impregnation of bed-nets, Bangladesh.

Mondal D, Huda MM, Karmoker MK, Ghosh D, Matlashewski G, Nabi SG, Kroeger A.

Emerg Infect Dis. 2013 Jul;19(7):1131-4. doi: 10.3201/eid1907.120932.PMID:23764246

Toolkit for monitoring and evaluation of indoor residual spraying for visceral leishmaniasis control in the Indian subcontinent: application and results.

Huda MM, Mondal D, Kumar V, Das P, Sharma SN, Das ML, Roy L, Gurung CK, Banjara MR, Akhter S, Maheswary NP, Kroeger A, Chowdhury R.

J Trop Med. 2011;2011:876742. doi: 10.1155/2011/876742. Epub 2011 Jul 27.PMID:21811510

 


Insecticide-treated bed nets in rural Bangladesh: their potential role in the visceral leishmaniasis elimination programme.

Mondal D, Chowdhury R, Huda MM, Maheswary NP, Akther S, Petzold M, Kumar V, Das ML, Gurung CK, Ghosh D, Kroeger A.

Trop Med Int Health. 2010 Nov;15(11):1382-9. doi: 10.1111/j.1365-3156.2010.02635.x. Epub 2010 Oct 13.PMID:20946233

Chemical and environmental vector control as a contribution to the elimination of visceral leishmaniasis on the Indian subcontinent: cluster randomized controlled trials in Bangladesh, India and Nepal.

Joshi AB, Das ML, Akhter S, Chowdhury R, Mondal D, Kumar V, Das P, Kroeger A, Boelaert M, Petzold M.

BMC Med. 2009 Oct 5;7:54. doi: 10.1186/1741-7015-7-54.PMID:19804620

Relationship between sand fly fauna and kala-azar endemicity in Bangladesh.

Alam MS, Wagatsuma Y, Mondal D, Khanum H, Haque R.

Acta Trop. 2009 Oct;112(1):23-5. doi: 10.1016/j.actatropica.2009.05.021. Epub 2009 Jun 6.PMID:19501561

Present situation of vector-control management in Bangladesh: a wake up call.

Mondal D, Alam MS, Karim Z, Haque R, Boelaert M, Kroeger A.

Health Policy. 2008 Sep;87(3):369-76. doi: 10.1016/j.healthpol.2008.01.011. Epub 2008 Mar 14.PMID:18342389

User friendliness, efficiency & spray quality of stirrup pumps versus hand compression pumps for indoor residual spraying.

Kumar V, Kesari S, Chowdhury R, Kumar S, Sinha G, Hussain S, Huda MM, Kroeger A, Das P.
Indian J Med Res. 2013;138:239-43.PMID:24056601

Comparison of insecticide-treated nets and indoor residual spraying to control the vector of visceral leishmaniasis in Mymensingh District, Bangladesh.

Chowdhury R, Dotson E, Blackstock AJ, McClintock S, Maheswary NP, Faria S, Islam S, Akter T, Kroeger A, Akhter S, Bern C.
Am J Trop Med Hyg. 2011 May;84(5):662-7. doi: 10.4269/ajtmh.2011.10-0682.PMID:21540372

Factors associated with visceral leishmaniasis in Nepal: bed-net use is strongly protective.

Bern C, Joshi AB, Jha SN, Das ML, Hightower A, Thakur GD, Bista MB.
Am J Trop Med Hyg. 2000 Sep-Oct;63(3-4):184-8.PMID:11388512

Vector control interventions for visceral leishmaniasis elimination initiative in South Asia, 2005-2010.

Picado A, Dash AP, Bhattacharya S, Boelaert M.
Indian J Med Res. 2012 Jul;136(1):22-31. Review.PMID:22885260

Application of RFLP-PCR-Based Identification for Sand Fly Surveillance in an Area Endemic for Kala-Azar in Mymensingh, Bangladesh.

Alam MS, Kato H, Fukushige M, Wagatsuma Y, Itoh M.
J Parasitol Res. 2012;2012:467821. doi: 10.1155/2012/467821. Epub 2012 May 31.PMID:22701164

Relationship between sand fly fauna and kala-azar endemicity in Bangladesh.

Alam MS, Wagatsuma Y, Mondal D, Khanum H, Haque R.
Acta Trop. 2009 Oct;112(1):23-5. doi: 10.1016/j.actatropica.2009.05.021. Epub 2009 Jun 6.PMID:19501561

Visceral leishmaniasis on the Indian sub-continent: a multi-centre study of the costs of three interventions for the control of the sandfly vector, Phlebotomus argentipes.

Das M, Banjara M, Chowdhury R, Kumar V, Rijal S, Joshi A, Akhter S, Das P, Kroeger A.
Ann Trop Med Parasitol. 2008 Dec;102(8):729-41. doi: 10.1179/136485908X355274. PMID:19000390

Vector control by insecticide-treated nets in the fight against visceral leishmaniasis in the Indian subcontinent, what is the evidence?

Ostyn B, Vanlerberghe V, Picado A, Dinesh DS, Sundar S, Chappuis F, Rijal S, Dujardin JC, Coosemans M, Boelaert M, Davies C.
Trop Med Int Health. 2008 Aug;13(8):1073-85. doi: 10.1111/j.1365-3156.2008.02110.x. Epub 2008 Jun 28.PMID:18564350

Long-lasting insecticidal nets fail at household level to reduce abundance of sandfly vector Phlebotomus argentipes in treated houses in Bihar (India).

Dinesh DS, Das P, Picado A, Davies C, Speybroeck N, Ostyn B, Boelaert M, Coosemans M.
Trop Med Int Health. 2008 Jul;13(7):953-8. doi: 10.1111/j.1365-3156.2008.02096.x. Epub 2008 May 8.PMID:18482197
Environment /Climate Change

Virgin soil: the spread of visceral leishmaniasis into Uttar Pradesh, India.

Barnett PG, Singh SP, Bern C, Hightower AW, Sundar S.
Am J Trop Med Hyg. 2005 Oct;73(4):720-5.PMID:16222016
National Kala-azar Elimination Program/ Operational Research

Feasibility of a combined camp approach for vector control together with active case detection of visceral leishmaniasis, post kala-azar dermal leishmaniasis, tuberculosis, leprosy and malaria in Bangladesh, India and Nepal: an exploratory study.

Banjara MR, Kroeger A, Huda MM, Kumar V, Gurung CK, Das ML, Rijal S, Das P, Mondal D.
Trans R Soc Trop Med Hyg. 2015 Jun;109(6):408-15. doi: 10.1093/trstmh/trv031. Epub 2015 Apr 26.PMID: 25918216

How far are we from visceral leishmaniasis elimination in Bangladesh? An assessment of epidemiological surveillance data.

Chowdhury R, Mondal D, Chowdhury V, Faria S, Alvar J, Nabi SG, Boelaert M, Dash AP.
PLoS Negl Trop Dis. 2014 Aug 21;8(8):e3020. doi: 10.1371/journal.pntd.0003020. eCollection 2014 Aug.PMID:25144317

Accelerated active case detection of visceral leishmaniasis patients in endemic villages of Bangladesh.

Khatun J, Huda MM, Hossain MS, Presber W, Ghosh D, Kroeger A, Matlashewski G, Mondal D.
PLoS One. 2014 Aug 4;9(8):e103678. doi: 10.1371/journal.pone.0103678. eCollection 2014. PMID:25090412

Active case detection in national visceral leishmaniasis elimination programs in Bangladesh, India, and Nepal: feasibility, performance and costs.

Huda MM, Hirve S, Siddiqui NA, Malaviya P, Banjara MR, Das P, Kansal S, Gurung CK, Naznin E, Rijal S, Arana B, Kroeger A, Mondal D.
BMC Public Health. 2012 Nov 20;12:1001. doi: 10.1186/1471-2458-12-1001.PMID:23164318

Options for active case detection of visceral leishmaniasis in endemic districts of India, Nepal and Bangladesh, comparing yield, feasibility and costs.

Singh SP, Hirve S, Huda MM, Banjara MR, Kumar N, Mondal D, Sundar S, Das P, Gurung CK, Rijal S, Thakur CP, Varghese B, Kroeger A.
PLoS Negl Trop Dis. 2011 Feb 8;5(2):e960. doi: 10.1371/journal.pntd.0000960.PMID:21347452

Enhanced case detection and improved diagnosis of PKDL in a Kala-azar-endemic area of Bangladesh.

Mondal D, Nasrin KN, Huda MM, Kabir M, Hossain MS, Kroeger A, Thomas T, Haque R.
PLoS Negl Trop Dis. 2010 Oct 5;4(10). pii: e832. doi: 10.1371/journal.pntd.0000832. PMID:20957193

Effectiveness and feasibility of active and passive case detection in the visceral leishmaniasis elimination initiative in India, Bangladesh, and Nepal.

Hirve S, Singh SP, Kumar N, Banjara MR, Das P, Sundar S, Rijal S, Joshi A, Kroeger A, Varghese B, Thakur CP, Huda MM, Mondal D.
Am J Trop Med Hyg. 2010 Sep;83(3):507-11. doi: 10.4269/ajtmh.2010.09-0685 PMID:20810811

Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy.

Mondal D, Singh SP, Kumar N, Joshi A, Sundar S, Das P, Siddhivinayak H, Kroeger A, Boelaert M.
PLoS Negl Trop Dis. 2009;3(1):e355. doi: 10.1371/journal.pntd.0000355. Epub 2009 Jan 13. PMID: 19159009

Leishmaniasis worldwide and global estimates of its incidence.

Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, den Boer M; WHO Leishmaniasis Control Team.
PLoS One. 2012;7(5):e35671. doi: 10.1371/journal.pone.0035671. Epub 2012 May 31.PMID:22693548

Complexities of assessing the disease burden attributable to leishmaniasis.

Bern C, Maguire JH, Alvar J.
PLoS Negl Trop Dis. 2008;2(10):e313. doi: 10.1371/journal.pntd.0000313. Epub 2008 Oct 29. Review.PMID:18958165

Performance of kala-azar surveillance in Gaffargaon subdistrict of Mymensingh, Bangladesh.

Rahman KM, Samarawickrema IV, Harley D, Olsen A, Butler CD, Sumon SA, Biswas SK, Luby SP, Sleigh AC.
PLoS Negl Trop Dis. 2015 Apr 10;9(4):e0003531. doi: 10.1371/journal.pntd.0003531. eCollection 2015 Apr.PMID:25860258

Visceral leishmaniasis in Nepal during 1980-2006.

Joshi DD, Sharma M, Bhandari S.
J Commun Dis. 2006 Mar;38(2):139-48.PMID:17370676

Can visceral leishmaniasis be eliminated from Asia?

Joshi A, Narain JP, Prasittisuk C, Bhatia R, Hashim G, Jorge A, Banjara M, Kroeger A.
J Vector Borne Dis. 2008 Jun;45(2):105-11. Review.PMID:18592839

Research priorities for elimination of visceral leishmaniasis.

Matlashewski G, Arana B, Kroeger A, Be-Nazir A, Mondal D, Nabi SG, Banjara MR, Das ML, Marasini B, Das P, Medley G, Satoskar A, Nakhasi H, Argaw D, Reeder J, Olliaro P.
Lancet Glob Health. 2014 Dec;2(12):e683-4. doi: 10.1016/S2214-109X(14)70318-3. No abstract available. PMID:25433617

Elimination of visceral leishmaniasis on the Indian subcontinent.

Singh OP, Hasker E, Boelaert M, Sundar S.
Lancet Infect Dis. 2016 Sep 28. pii: S1473-3099(16)30140-2. doi: 10.1016/S1473-3099(16)30140-2. Review.PMID:27692643

Visceral leishmaniasis: elimination with existing interventions.

Matlashewski G, Arana B, Kroeger A, Battacharya S, Sundar S, Das P, Sinha PK, Rijal S, Mondal D, Zilberstein D, Alvar J.
Lancet Infect Dis. 2011 Apr;11(4):322-5. doi: 10.1016/S1473-3099(10)70320-0. Review.PMID:21453873

Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal–the challenges for diagnosis and treatment.

Sundar S, Mondal D, Rijal S, Bhattacharya S, Ghalib H, Kroeger A, Boelaert M, Desjeux P, Richter-Airijoki H, Harms G.
Trop Med Int Health. 2008 Jan;13(1):2-5. doi: 10.1111/j.1365-3156.2007.01974.x. No abstract available. PMID:18290995

Visceral leishmaniasis and its control in Bangladesh.

Elias M, Rahman AJ, Khan NI.
Bull World Health Organ. 1989;67(1):43-9.PMID:2650901

Quantification of the natural history of visceral leishmaniasis and consequences for control.

Chapman LA, Dyson L, Courtenay O, Chowdhury R, Bern C, Medley GF, Hollingsworth TD.
Parasit Vectors. 2015 Oct 22;8:521. doi: 10.1186/s13071-015-1136-3.PMID:26490668

Understanding the transmission dynamics of Leishmania donovani to provide robust evidence for interventions to eliminate visceral leishmaniasis in Bihar, India.

Cameron MM, Acosta-Serrano A, Bern C, Boelaert M, den Boer M, Burza S, Chapman LA, Chaskopoulou A, Coleman M, Courtenay O, Croft S, Das P, Dilger E, Foster G, Garlapati R, Haines L, Harris A, Hemingway J, Hollingsworth TD, Jervis S, Medley G, Miles M, Paine M, Picado A, Poché R, Ready P, Rogers M, Rowland M, Sundar S, de Vlas SJ, Weetman D.
Parasit Vectors. 2016 Jan 27;9:25. doi: 10.1186/s13071-016-1309-8.PMID:26812963

Endemic transmission of visceral leishmaniasis in Bhutan.

Yangzom T, Cruz I, Bern C, Argaw D, den Boer M, Vélez ID, Bhattacharya SK, Molina R, Alvar J.
Am J Trop Med Hyg. 2012 Dec;87(6):1028-37. doi: 10.4269/ajtmh.2012.12-0211. Epub 2012 Oct 22.PMID:23091191

Natural history of a visceral leishmaniasis outbreak in highland Ethiopia.

Herrero M, Orfanos G, Argaw D, Mulugeta A, Aparicio P, Parreño F, Bernal O, Rubens D, Pedraza J, Lima MA, Flevaud L, Palma PP, Bashaye S, Alvar J, Bern C.
Am J Trop Med Hyg. 2009 Sep;81(3):373-7.PMID:19706898

Kala-azar outbreak in Libo Kemkem, Ethiopia: epidemiologic and parasitologic assessment.

Alvar J, Bashaye S, Argaw D, Cruz I, Aparicio P, Kassa A, Orfanos G, Parreño F, Babaniyi O, Gudeta N, Cañavate C, Bern C.
Am J Trop Med Hyg. 2007 Aug;77(2):275-82.PMID:17690399

Health-seeking behaviour, diagnostics and transmission dynamics in the control of visceral leishmaniasis in the Indian subcontinent.

Medley GF, Hollingsworth TD, Olliaro PL, Adams ER.
Nature. 2015 Dec 3;528(7580):S102-8. doi: 10.1038/nature16042.PMID:26633763

Resurgence of visceral leishmaniasis in Bangladesh.

Rahman KM, Islam N.
Bull World Health Organ. 1983;61(1):113-6.PMID:6601534
Bangladesh
Other Articles

RFLPs of ITS, ITS1 and hsp70 amplicons and sequencing of ITS1 of recent clinical isolates of Kala-azar from India and Bangladesh confirms the association of L. tropica with the disease.

Khanra S, Datta S, Mondal D, Saha P, Bandopadhyay SK, Roy S, Manna M.

Acta Trop. 2012 Dec;124(3):229-34. doi: 10.1016/j.actatropica.2012.08.017. Epub 2012 Aug 31.PMID:22960646

Visceral leishmaniasis clinical management in endemic districts of India, Nepal, and bangladesh.

Banjara MR, Hirve S, Siddiqui NA, Kumar N, Kansal S, Huda MM, Das P, Rijal S, Gurung CK, Malaviya P, Arana B, Kroeger A, Mondal D.

J Trop Med. 2012;2012:126093. doi: 10.1155/2012/126093. Epub 2012 May 9. PMID:22649459

How do health care providers deal with kala-azar in the Indian subcontinent?

Kumar N, Singh SP, Mondal D, Joshi A, Das P, Sundar S, Kroeger A, Hirve S, Siddiqui NA, Boelaert M.

Indian J Med Res. 2011 Sep;134:349-55.PMID:21985818

Characterisation of antimony-resistant Leishmania donovani isolates: biochemical and biophysical studies and interaction with host cells.

Mukhopadhyay R, Mukherjee S, Mukherjee B, Naskar K, Mondal D, Decuypere S, Ostyn B, Prajapati VK, Sundar S, Dujardin JC, Roy S.

Int J Parasitol. 2011 Nov;41(13-14):1311-21. doi: 10.1016/j.ijpara.2011.07.013. Epub 2011 Sep 7.PMID:21920365

Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal–the challenges for diagnosis and treatment.

Sundar S, Mondal D, Rijal S, Bhattacharya S, Ghalib H, Kroeger A, Boelaert M, Desjeux P, Richter-Airijoki H, Harms G.

Trop Med Int Health. 2008 Jan;13(1):2-5. doi: 10.1111/j.1365-3156.2007.01974.x. No abstract available. PMID:18290995

Visceral leishmaniasis-associated mortality in Bangladesh: a retrospective cross-sectional study.

Huda MM, Chowdhury R, Ghosh D, Dash AP, Bhattacharya SK, Mondal D.

BMJ Open. 2014 Jul 22;4(7):e005408. doi: 10.1136/bmjopen-2014-005408.PMID:25052172

Kala-azar in pregnancy in Mymensingh, Bangladesh: a social autopsy.

Rahman KM, Olsen A, Harley D, Butler CD, Mondal D, Luby SP, Sleigh AC.

PLoS Negl Trop Dis. 2014 May 1;8(5):e2710. doi: 10.1371/journal.pntd.0002710. eCollection 2014 May. No abstract available. PMID:24786280

Introducing single dose liposomal amphotericin B for the treatment of visceral leishmaniasis in rural bangladesh: feasibility and acceptance to patients and health staff.

Maintz EM, Hassan M, Huda MM, Ghosh D, Hossain MS, Alim A, Kroeger A, Arana B, Mondal D.

J Trop Med. 2014;2014:676817. doi: 10.1155/2014/676817. Epub 2014 Jan 21.PMID:24578710

Visceral Leishmaniasis Eradication is a Reality: Data from a Community-based Active Surveillance in Bangladesh.

Ferdousi F, Alam MS, Hossain MS, Ma E, Itoh M, Mondal D, Haque R, Wagatsuma Y.

Trop Med Health. 2012 Dec;40(4):133-9. doi: 10.2149/tmh.2012-25. Epub 2012 Dec 22.PMID:23532674

Low prevalence of Leishmania donovani infection among the blood donors in kala-azar endemic areas of Bangladesh.

Huda MM, Rudra S, Ghosh D, Bhaskar KR, Chowdhury R, Dash AP, Bhattacharya SK, Haque R, Mondal D.

BMC Infect Dis. 2013 Feb 2;13:62. doi: 10.1186/1471-2334-13-62.PMID:23375008

Survey of domestic cattle for anti-Leishmania antibodies and Leishmania DNA in a visceral leishmaniasis endemic area of Bangladesh.

Alam MS, Ghosh D, Khan MG, Islam MF, Mondal D, Itoh M, Islam MN, Haque R.

BMC Vet Res. 2011 Jun 8;7:27. doi: 10.1186/1746-6148-7-27. PMID:21651757

The epidemiology of visceral leishmaniasis in Bangladesh: prospects for improved control.

Bern C, Chowdhury R.
Indian J Med Res. 2006 Mar;123(3):275-88. Review.PMID:16778310

The economic impact of visceral leishmaniasis on households in Bangladesh.

Anoopa Sharma D, Bern C, Varghese B, Chowdhury R, Haque R, Ali M, Amann J, Ahluwalia IB, Wagatsuma Y, Breiman RF, Maguire JH, McFarland DA.
Trop Med Int Health. 2006 May;11(5):757-64. Erratum in: Trop Med Int Health. 2006 Sep;11(9):1482. PMID:16640630

Visceral leishmaniasis: consequences to women in a Bangladeshi community.

Ahluwalia IB, Bern C, Wagatsuma Y, Costa C, Chowdhury R, Ali M, Amann J, Haque R, Breiman R, Maguire JH.
J Womens Health (Larchmt). 2004 May;13(4):360-4.PMID:15186651

Visceral leishmaniasis: consequences of a neglected disease in a Bangladeshi community.

Ahluwalia IB, Bern C, Costa C, Akter T, Chowdhury R, Ali M, Alam D, Kenah E, Amann J, Islam M, Wagatsuma Y, Haque R, Breiman RF, Maguire JH.
Am J Trop Med Hyg. 2003 Dec;69(6):624-8.PMID:14740879

Leishmaniasis and poverty.

Alvar J, Yactayo S, Bern C.
Trends Parasitol. 2006 Dec;22(12):552-7. Epub 2006 Oct 4.PMID:17023215

Human resource assessment for scaling up VL active case detection in Bangladesh, India and Nepal.

Naznin E, Kroeger A, Siddiqui NA, Sundar S, Malaviya P, Mondal D, Huda MM, Das P, Karki P, Banjara MR, Dreesch N, Gedik G.
Trop Med Int Health. 2013 Jun;18(6):734-42. doi: 10.1111/tmi.12124. Epub 2013 May 8.PMID:23651494

Visceral Leishmaniasis Eradication is a Reality: Data from a Community-based Active Surveillance in Bangladesh.

Ferdousi F, Alam MS, Hossain MS, Ma E, Itoh M, Mondal D, Haque R, Wagatsuma Y.
Trop Med Health. 2012 Dec;40(4):133-9. doi: 10.2149/tmh.2012-25. Epub 2012 Dec 22.PMID:23532674

Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control.

Stauch A, Sarkar RR, Picado A, Ostyn B, Sundar S, Rijal S, Boelaert M, Dujardin JC, Duerr HP.
PLoS Negl Trop Dis. 2011 Nov;5(11):e1405. doi: 10.1371/journal.pntd.0001405. Epub 2011 Nov 29.PMID:22140589

Survey of domestic cattle for anti-Leishmania antibodies and Leishmania DNA in a visceral leishmaniasis endemic area of Bangladesh.

Alam MS, Ghosh D, Khan MG, Islam MF, Mondal D, Itoh M, Islam MN, Haque R.
BMC Vet Res. 2011 Jun 8;7:27. doi: 10.1186/1746-6148-7-27.PMID:21651757

Kala azar in Pregnancy.

Miah MT, Ayaz FM, Maniruzzaman M, Ahasan MN, Bari S, Mawla SM, Mahbub MS, Khan AI.
Mymensingh Med J. 2010 Oct;19(4):529-32.PMID:20956894

A cost benefit analysis of elimination of kala-azar in Indian subcontinent: an example of Nepal.

Adhikari SR, Supakankunti S.
J Vector Borne Dis. 2010 Sep;47(3):127-39.PMID:20834081

Cutaneous leishmaniasis.

Ahmed Z, Chowdhury SA, Bhuiyan SI.
Mymensingh Med J. 2009 Jul;18(2):260-3.PMID:19623158

Relationship between sand fly fauna and kala-azar endemicity in Bangladesh.

Alam MS, Wagatsuma Y, Mondal D, Khanum H, Haque R.
Acta Trop. 2009 Oct;112(1):23-5. doi: 10.1016/j.actatropica.2009.05.021. Epub 2009 Jun 6.PMID:19501561

Epidemiological characteristics of sixty five cases of Kala-azar attending to a laboratory in Mymensingh.

Talukder SI, Huq MH, Rahman S, Haque MA, Sarker CB, Ali MS.
Mymensingh Med J. 2003 Jul;12(2):89-92.PMID:12894039

Clinical profile of Kala-azar in adults: as seen in Mymensingh Medical College Hospital, Mymensingh, Bangladesh.

Sarker CB, Chowdhury KS, Siddiqui NI, Jamal MF, Rahman S, Momen A, Dhar DK, Alam KS.
Mymensingh Med J. 2003 Jan;12(1):41-4.PMID:12715642

Characterisation of Bangladeshi Leishmania isolated from kala-azar patients by isoenzyme electrophoresis.

Shamsuzzaman SM, Furuya M, Shamsuzzaman Choudhury AK, Korenaga M, Hashiguchi Y.
Parasitol Int. 2000 Aug;49(2):139-45.PMID:10882903

Epidemiology of visceral leishmaniasis in India.

Bora D.
Natl Med J India. 1999 Mar-Apr;12(2):62-8. Review.
PMID:10416321